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SUMMARY 
Skeletal muscle represents the most abundant tissue in the human body and is one of the 
most important sites of metabolic control. Nitric oxide (NO), generated in skeletal muscle 
mostly by the neuronal NO synthases (nNOSµ), has several effects on muscle 
development and function [1], indeed nNOS signaling is defective in many skeletal 
muscle diseases contributing to muscle degeneration. Moreover NO in also relevant for 
mitochondria structure and function [2-3] and could be involved in the control of 
mitochondrial turnover [4]. Autophagy is constantly active in skeletal muscle and its role 
in tissue homeostasis is complex: at high levels, it can be detrimental and contribute to 
muscle wasting; at low levels, it can cause weakness and muscle degeneration, due to 
accumulation of damaged proteins and organelles and recently many studies have 
highlighted the importance of autophagy in the pathogenesis of muscle wasting in 
different types of inherited muscle disorders.  
My phD project is divided in two sections: the formeris focused on the study of the 
relationship between the NO system, mitochondrial structure/activity and skeletal muscle 
wasting, paying attention on the role of autophagy and using a mouse model in which 
NOS1 (nNOSµ) is absent. The latter has examined the role of autophagy in myogenic 
precursor cells(satellite cells) and muscle development utilizing a model of skeletal 
muscle specific autophagy-knockout mice. The first important observation was that the 
deficit in NO signaling in skeletal muscle leads to alterations in mitochondrial 
morphology and network remodeling, associated with enhanced autophagy. NOS1-/- 
mice showed a disorganized mitochondrial network and. an active autophagic pathway, in 
tibialis anterior and diaphragm muscles of P120 NOS1-/- mice. 
Then we evaluated the effects of the absence of NOS1 (nNOSµ) on skeletal muscle 
phenotype. The body weight and the visceral adipose tissue of NOS1-/- mice were 
significantly lower than wild-type control, moreover the same occurred with the relative 
muscle mass (normalized to body weight), demonstrated to be reduced compared with 
control. The overall morphology of the tibialis anterior and diaphragm muscle in P120 
NOS1-/- mice was normal, without pathological features of necrosis, macrophage 
infiltration and centronucleated fibers. By contrast, laminin staining of tibialis anterior 
and diaphragm, used to identify individual muscle fibers, revealed a significant decrease 
in the mean CSA of tibialis anterior and diaphragm sections in P120 NOS1-/- mice when 
compared with control. The examination of multiple time points was then carried out in 
4 
 
order to establish a possible link between the changes in mitochondrial homeostasis and 
the reduction in muscle size. Furthermore, the observation that at different time point 
NOS1-/- and control mice expressed similar levels of transcripts encoding the classical 
atrogenes atrogin-1 and MuRF1, indicates that the atrophy pathways do not play a key 
role in the development of NOS1-/- muscles.  
So far my data demonstrate that an altered NO signaling leads to mitochondrial 
dysfunction resulting in enhanced autophagy and reduced muscle growth, however not 
associated with atrophy induction. Also in my model the absence of NOS1 altered 
mitochondrial homeostasis and autophagic pathway in myogenic precursor cells with a 
decrease in the number of myonuclei per fibres and impaired muscle development at 
early stages of growth. An altered NO signaling in myogenic precursor cells led to 
mitochondrial network fragmentation and increased autophagy induction resulting in 
significant defects in myogenesis process both in vivo and in vitro, decreasing muscle 
development [5]. 
However, autophagy is essential to maintain muscle mass, but its role on regenerating 
population and its impacton muscle growth and development has not been evaluated yet. 
Starting form conclusion in the second part of my PhD project I focalized my attention on 
the role of autophagy specifically on satellite cells population, generating a transgenic 
mice in which autophagy is selectively inhibited in satellite cells and studying their 
impact on muscle growth. 
To generate the mice we crossed Atg7-floxed mice with a transgenic line expressing Cre 
recombinase under the control of the Pax7 promoter in order to generate satellite cells 
lacking the autophagy gene Atg7 [6]. Measuring body weight after birth we detected very 
significant differences between control and Ag7 -/- mice with the last one smaller than 
control littermates. Normalizing all the organs weight to the body weight we 
demonstrated that only the skeletal muscle tissue was smaller out-of-proportion to the 
body weight in Atg7-/- mice, suggesting that a defective autophagy in satellite cells 
population causes a muscular phenotype more serious, but with some similarities 
withNOS1 -/- mice, in spite of opposing autophagy conditions. 
To better understand the nature of the hypotrophic skeletal muscle observed in Atg7 -/- 
mice, skeletal muscle sections from male Atg7-/- and control mice at p21 days after birth 
were stained by hematoxylin and eosin (H&E) or immunostained with an anti-Laminin 
antibody. The overall morphology of the tibialis anterior of Atg7-/- mice was normal, 
without pathological features of necrosis, macrophage infiltration and centronucleated 
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fibers, conversely laminin staining revealed a significant decrease in the mean CSA in 
Atg7-/- mice when compared with control littermates. Also, we examined the mRNA 
levels of Myostatin and MuRF1 and Atrogin for atrophic pathway and none of them were 
significantly changed, demonstrating that loss autophagy does not affect this pathways. 
However skeletal muscle growth is dependent on the proliferative expansion of satellite 
cells and the balance between the proliferation of myogenic progenitors and their 
differentiation into muscle fibers, but was no significant difference in the average number 
of satellite cells in muscle. Thus, we evaluated whether loss of Atg7 could affect the 
proliferation of these cells and we shows a lower proliferation rate of Atg7-/- satellite 
cells.  
To gain further insight into the role of autophagy on satellite cells we evaluated the 
myogenic cell determination on isolated myofibers after 48h of proliferation. Analyzing 
immunofluorescence for Pax7 and MyoD we observed that the number of MyoD+/Pax7-
(cells committed to differentiated) decreased in Atg7-/- fibers. There was no significant 
differences in the number of MyoD+/Pax7+ (activated cells), whereas increased the 
number of Pax7+/MyoD-(quiescent cells) cells was detected in Atg7-/- fibers, suggesting 
a delay of satellite cells to progress into myogenic lineage and the presence of more cells 
in quiescent state. Finally we analyzed the ability of satellite cells to fuse and 
differentiate. Satellite cells isolated from Atg7 -/- mice after 48h in differentiation 
medium showed a reduced ability to fuse and a sharp decrease in myotubes diameter 
associated with reduced expression of myogenic markers . 
Taken together, our data suggest that autophagy is involved in the controlling of satellite 
cells functions. Autophagy loss of function in satellite cells impairs their proliferation rate 
as well as their capability to fuse and differentiate and these results explain, at least in 
part, because the muscles of the Atg7-/- mice are smaller than the muscles of control 
mice. 
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INTRODUCTION 
 
Chapter 1 : Satellite cells and skeletal muscle 
 
1.1 SKELETAL MUSCLE  
Skeletal muscle tissue represents the most abundant tissue in the human body, amounting 
to 60% of the average weight. From a metabolic point of view it is very active and 
requires a constant flow of nutrients and metabolites, provided by an extensive capillary 
network forming an organized branching pattern throughout the fibers. 
The structure of skeletal muscle is characterized by very well organized structure 
composed of parallel elements that can be divided in myofibrils, muscle fibers and 
fascicles (Fig 1). 
The myofibrils are the cytoplasmic molecular machinery capable of performingmuscle 
contraction.They are bundled within the cytoplasm generating a multinucleated 
syncytium containing muscle cell or myofiber. The contraction of the myofibrils also 
depends on motoneuron connections that regulate the calcium required for contraction 
through the sarcoplasmic reticulum. 
 
 
Figure 1 Schematic representation of skeletal muscle structure 
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Each myofibril is divided into segments calledsarcomeres, that are the contractile units of 
a muscle. Sarcomeres are composed ofthickfilamentsandthin filaments. The thin 
filaments are attached at one end to a Z disc, a dark stripe that marks the ends of one 
sarcomere and the beginning of the next and extend toward the center of the sarcomere. 
The thick filaments, by contrast, lie at the center of the sarcomere and overlap the thin 
filaments. 
Myofibers constitute the parenchyma of skeletal muscle, and are bundled in a complex 
extracellular matrix structure which connects them to the muscle-tendon junction through 
three fibrous layers: the endomysium, surrounding individual myofibers, the perimysium, 
found over fascicles and the epimysium which cover the entire muscle. 
Blood vessels are presentalong the fascicles in the perimysium, diffuseinto the 
endomysium, where they generatecapillaries that project around the myofibers andeach 
myofiber is connected to a capillary allowing the metabolic support of skeletal muscle.  
Following blood vessels, also the axons of motorneurons, which transmit the synaptic 
signal to the myofibers terminate into neuromuscular junctions in the proximity of 
sarcolemma connections(triads)[7]. 
Skeletal muscles of adult mammalian species exhibit a remarkable capacity to adapt to 
physiological demands such as growth, training, and injury. The processes are largely 
attributed to asmall population of cells that are resident in adult skeletal muscle. 
Satellite cells (SC) responsible for the maintenance and the continual production on 
myoblasts. Once activated, SCs will start dividing and producing muscle progenitor cells 
(MPCs) that will become myoblasts and fuse to the existing myofibers[8].SC pools can 
be replenished by muscular tissue pericytes (MPs), a population of cells that surround the 
endothelium of small vessels. They regulate numerous functions, such as vessel growth, 
stabilization, and permeability[9].They show the ability to undergo skeletal muscle 
myogenesis, on proper culture conditionsindeed it has been shown that cells from the 
vessel wall may receive signals instructing them to adopt the fate of the specific tissue, 
skeletal muscle in this case. 
Finally, fibro/adipogenic progenitors (FAPs), presentin  a quiescence state near blood 
vessels, are activated in case of muscle injury. FAP cells are known to promote the 
differentiation of MPCs but do not have any capability to generate muscle tissue on their 
own; on the contrary, they appear to be the main source of the fibrotic and adipose tissues 
found in pathological muscles[10]. The interplay between these cell populations is 
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fundamental for the continuous renewal of skeletal muscle tissue, required to compensate 
the damage occurring in day-to-day activities; however, pathological states also require 
the activation of the same cells in different processes that can result in the regeneration of 
the tissue or the formation of a fibrotic scar. 
 
1.2  SATELLITE CELLS 
 
1.2.1 Morphology and location of satellite cells 
Satellite cells (SCs) are the muscle stem cells responsible for longitudinal and cross-
sectional postnatal growth and repair after injury providing new myonuclei when needed. 
Alexander Mauro [11]first discovered and namedthe satellite cell (SC) in frog skeletal 
muscle based on its peripheral location in the myofiber, identified between the 
sarcolemma and basal lamina. In terms of location, SCs have a similar position to skeletal 
muscle myonuclei, namely on the periphery of the myofiber but outside the sarcolemma, 
whilemyonuclei are just under the sarcolemma. In other words, SCs represent a 
differentcell population into themyofibers (figure 2). 
 
 
Figure 2 Satellite cells oppupy a sublaminar position in adult skeletal muscle 
 
Satellite cell number depends on the species, age, and muscle fiber type . They constitute 
30% of the muscle nuclei in the new bornand decrease with age to 4% in the adult and 
2% in the senile (29–30 mo) mice[12].  
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SC distribution between muscle groups depends on their heterogeneous contentin 
different muscle type. An increase in satellite cell density has been demonstrated in 
association with the proximity of capillaries, myonuclei, and motoneuron junctions, in 
fact oxidative fibers, characterized by increased capillary and motoneuron density 
compared with glycolytic myofibers, demonstrate a five to six times greater satellite cell 
content[13]. 
Instead the decrease in the percentage of satellite cells with aging is the result of a 
decrease in total number of satellite cells and although the functional consequences of SC 
number decline are unclear, it is becoming clear that SC function changes profoundly 
with aging[14]. 
Morphologically satellite cells populationare characterized by a relatively high nuclear-
to-cytoplasmic ratio with few organelles, a smaller nuclear size compared with the 
adjacent nucleus of the myotube, and an increasedamount of nuclear heterochromatin 
compared with that of the myonucleus These morphological features are consistent with 
the finding that satellite cells are relatively quiescent and transcriptionally less active. 
These features are lossfollowing activation or proliferation of the satellite cells in 
response to growth, remodeling, or muscle injury. After activation, the satellite cells are 
more easily identified, they are characterized bycytoplasmic processes that extend from 
one or both poles of the cell, by reduction of heterochromatin due to increased mitotic 
activity, by increased cytoplasmic-to-nuclear ratio, and an increase in the number of 
intracellular organelles[15]. 
 
1.2.2 Myogenic factors 
Many similarities between the activation of satellite cells and somite myogenesis have 
supported the idea that adult muscle regeneration to a certain extent recapitulates 
embryonic development through analogous, but not identical, mechanisms[16-17]. 
Consistently with the establishment of embryonic progenitors in the myotome , the 
activation, proliferation and differentiation of satellite cells are processes regulated by a 
family of transcription factors known as myogenic regulation factors (MRFs) and among 
them, the basic helix–loop–helix (bHLH) transcription factors myogenic factor 5 (MYF5) 
and myoblast determination protein (MYOD) together with muscle-specific regulatory 
factor 4 (MRF4; also known as MYF6) and Myogenin are upregulated during myoblast 
differentiation. Together these myogenic regulatory factors transcriptionally and 
epigenetically determine the myogenic capacity of muscle progenitors (figure 3). 
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Mice lacking MyoD have quite normal muscle but express about fourfold higher levels of 
MYF5. In agreement also MYF5 deficient mice have normal muscle. However, mice 
lacking both Myf5 and MyoD are totally devoid of myoblasts and myofibres, indicating 
that these genes are required for the determination of myogenic precursors. [18-19]. As a 
downstream target of MYOD, myogenin regulates the transition from myoblasts into 
myocytes and myotubes and, although myogenin-knockout mice show proper 
compartmentalization of muscle groups, they almost completely lack myofibres and 
accumulate undifferentiated myoblasts[20]. Thus, MYF5 and MYOD are required for the 
determination of myogenic precursors and act upstream of myogenin and MRF4, which 
are required for terminal differentiation. 
 
 
Fig 3 Satellite cell (SC) location and function. A) The SC is anatomically located between the myofiber 
basal lamina and sarcolemma. B) The relationship between gene expression and SC activation, self-
renewal, proliferation, differentiation and fusion with existing myofiber. 
 
Somitic myogenic progenitors, that eventually give rise to satellite cells, express PAX3 
and/ or PAX7 two closely related paired domain homeobox transcription factors and do 
not express MRFs. These progenitor PAX3+PAX7+cells upregulate MYF5 and MYOD 
when they enter into the myogenic differentiation programme, or remain as satellite cells 
without upregulating MRFs. In particular PAX3 and PAX7 play key rolein maintaining 
the proliferation of progenitors and preventing early differentiation.  
Belonging to the PAX family of transcription factors, PAX3 and PAX7 are paralogues 
with conserved amino acid sequences and have almost identical sequence-specific DNA-
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binding motifs. Despite this homology, PAX3 and PAX7 have overlapping but non-
redundant roles in the myogenic programme. 
Lineage-tracing studies suggest that PAX3+cells contribute to embryonic myoblasts and 
endothelial lineage, whereas PAX7+cells contribute to fetal myoblasts, supporting the 
notion that these cells represent distinct myogenic lineages[21].  
PAX3 expression is abundant in the embryo then after birth it is downregulated, 
suggesting that it has little function in satellite cells indeed prolonged expression of 
PAX3, by preventing its proteosomal degradation, results in the inhibition of terminal 
differentiation[22]. Conversely PAX7 is expressed by all satellite cells and proliferating 
myoblasts but is quickly downregulated before differentiation[23].  
Pax7 is involved in the specification of the myogenic identity and the maintenance of the 
undifferentiated state. Ectopic overexpression of PAX7 in C2C12 myoblasts and primary 
myoblasts suggests that PAX7 drives the expression of Myf5 but not MyoD[24]. 
Moreover, PAX7 has been shown to directly activate Myf5 by promoting the recruitment 
of the ASH2-like (ASH2L)–MLL2 histone methyltransferase complex at a regulatory 
element of the Myf5 coding region, indicating that PAX7 can epigenetically specify the 
myogenic identity of satellite cells. PAX7 expression correlates with an undifferentiated 
but committed myogenic state, indicating that PAX7 in the early postnatal period 
probably worksto prevent the transition into terminal differentiation maintaining the 
myogenic identity by promoting MYF5 expression. Both functions allow PAX7 to 
specify the satellite cell lineage. Therefore, satellite stem cells (PAX7+MYF5) in adult 
muscle may represent a lineage of the embryonic PAX3+PAX7+MRF– progenitors[25]. 
 
1.2.3 Muscle regeneration: quiescence, activation and self renewal 
Muscle regeneration is characterized by different myogenic stages, namely: activation, 
proliferation, differentiation, and self-renewal/return to quiescence. Careful regulation of 
the cell cycle is essential to ensure appropriate progression through these various 
overlapping states. In resting adult muscles, satellite cells exist in a dormant state known 
as quiescence or the reversible G0 state. The ability of satellite cells to maintain 
quiescence is essential for the long-term conservation of the satellite cell pool [26-27]. 
This quiescent state is distinct from the cell cycle exit observed prior to differentiation, 
which allows cells to return to a proliferative state in response to injury. The quiescent 
state is highly regulated and represents a ‘ready’ state that is primed for activation. 
Microarray analyses revealed that more than 500 genes are highly upregulated in 
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quiescent satellite cells compared with cycling myoblasts [28-29]. These quiescence 
genes act in concert to prevent the early activation of quiescent satellite cells because 
impairments in the ability of satellite cells to maintain quiescence reduce self-renewal 
capacity and muscle regeneration. 
Mitogenic factors liberated following injury drive quiescent satellite cells to re-enter the 
cell cycle[30] (Figure 4). 
Recent analyses of systemic effects of muscle injury reveal an intermediate state between 
the G0 quiescent and activated cell states, termed G alert. It has beenshown that, 
following muscle injury, satellite cells from the controlateral uninjured leg are 
phenotypically different from classical quiescent cells. They are larger, have more 
intracellular ATP and higher metabolic activity than quiescent satellite cells and express a 
number of cell cycle genes similar to those expressed in activated satellite cells, but they 
do not proliferate or enter in the cell cycle. 
 
 
Figure 4 Regulation of the cell cycle in satellite cells. 
 
This intermediate GAlert state allows satellite cells to perform their first division faster 
than satellite cells in the G0 state, finally satellite cells in the GAlert state have greater 
regenerative potential[31]. This supportsthe existence of a system-wide response 
mechanism that inducessatellite cells to become activated in a regenerative environment. 
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Damaged muscles release various growth factors that activate signaling pathways 
involved in satellite cell cycle entry such as insulin-like growth factor (Igf1) [32-33] and 
Fgf2[34]. 
Once activated, satellite cells can undergo differentiation (into myocytes) or return to 
quiescence, two processes that involve cell cycle exit. 
In addition to re-entering the cell cycle, activated satellite cells canalso determine the cell 
fate of their daughter cells, in particular whether they self-renew or generate myogenic 
progenitors.  
The analysis of MRF expression in proliferating satellite cells shows an asymmetric 
expression of determination factors, including Myf5, MyoD and Myog, in the daughter 
cells after satellite cell divisions. Indeed stem cell subpopulations are able to undergo 
both symmetric and asymmetric types of self-renewal to maintain their numbers. 
Asymmetric divisions generatestwo identical daughter cells to increase the satellite stem 
cell pool. Alternatively, satellite stem cells can perform asymmetric divisions, which 
generate only one stem cell and one committed daughter cell that will go through the 
myogenic lineage (Figure 5). 
 
 
 
Figure 5 Satellite cell fate decisions. 
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Symmetric division is induced by activation of the planar cell polarity (PCP) pathway, 
leading to the symmetric distribution of effectors in daughter cells, while during 
asymmetric division segregation of different cell fate determinants is observed[35]. 
Satellite cells are able toselectthe type of division to performallowing them to coordinate 
their activity with the needs of the regenerating muscle. For example, an increased 
symmetric divisions would be useful for the expansion of the satellite stem cell pool, 
whereas increased asymmetric divisions would enhanceboth the generation of myogenic 
progenitors and maintenance of the stem cell pool. 
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Chapter 2 Nitric Oxide 
 
In mammals, including humans, Nitric Oxide(NO) is a ubiquitous, diffusible, gaseous 
messenger and an important regulator involved in many physiological and pathological 
processes. For instance, in the neuronal, cardiovascular, gastrointestinal and other 
systems NO mediates its biological effects through hemeproteinguanylatecyclase, which 
activates the enzyme and thereby raises cGMPlevels.However, other important effects of 
NO in the vasculature such as cytoprotection and anti-adhesion appear to be mediated 
through cGMP independent signaling. Likewise, NO regulation of inflammation has 
frequently been associated withsignal transduction events that do not involve cGMP. 
NO has been documented to produce a variety of effects changing from its 
centralneurotransmitterto peripheral actions which propose it to be a therapeutic target in 
aging, apoptosis, diabetes, inflammation, ischemic preconditioning . 
NO is synthesized from L-arginine and oxygen (figure 6) by NO synthases (NOS) which 
are the products of three different genes and named as neuronal nNOS (NOS1), 
inducibleiNOS (NOS2), and endothelial eNOS (NOS3). 
 
 
 
Figure 6 Nitric oxide synthases catalyze the production of NO and L-citrulline from L-arginine, O2, and 
NADPH-derived electrons 
 
All NOS isoforms share between 50 and 60% sequence homology and require same co-
substrates (molecular oxygen, NADPH) and co-factors (FMN, FAD, 
tetrahydrobiopterinand Zn++ions). FAD, FMN and heme are involved in redox reactions 
leading to synthesis of NO.  
The three NOS isoforms differ in their mechanisms of activation, regulation and catalytic 
activity. Neuronal and endothelial NOS are constitutively expressed and require 
Ca2+/calmodulin complex for their activation. Both nNOS and eNOSproduce NO at low, 
physiological levels (nanomolar range) for short periods. Conversely iNOS is expressed 
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in skeletal muscle primarily under severe inflammatory conditions, such as in the course 
of autoimmune inflammatory myophaties[36], and after crash injury [37]. The activity of 
iNOS is independent of the Ca2+/calmodulin complex, and generates NO at high 
concentrations (micromolar range) for prolonged periods of time. 
Studies have recently identified a putative fourth NOS isoform, named mitochondrial 
NOS (mtNOS), whose nature is still highly debated; it is a constitutive protein sitting on 
the mitochondrial inner membrane at the matrix side, that generates NO in a Ca2+-
dependent reaction [38-39]. Most evidence support the notion that mtNOS is mostly a 
variant of nNOS α. 
The different NOS isoforms display tissue and cell type distribution and activity. eNOS is 
anchored to the outer mitochondrial membrane in neurons and endothelial cells[40], 
which indicates that mitochondria might regulate NOS activity and, conversely, that 
eNOS might regulate mitochondrial function. nNOS is expressed in peripheral and 
central nervous system, where NO is a signal molecule for cell-to-cell communication 
and neuroplasticity [41]. Finally mtNOS plays a role in the regulation of bioenergetics 
and Ca2+ buffering[38, 42]. 
NO affects mitochondrial function at different levels: it regulates blood flow to tissues, 
therefore it supplies respiratory substrates to the organelles and redistributes heat 
generated by respiring mitochondria. NO also regulates mitochondrial function by 
reversible binding to cytochrome C oxidase in competition with oxygen to negatively 
regulate the respiratory complex, inhibiting oxidative phosphorylation at low oxygen 
concentration. This NO-dependent inhibition of cell respiration is important as part of the 
adaptive response to stress,e.g. in thedefence from alcohol toxicity [43] and in response 
to cardiac failure [44].  
NO also binds to soluble guanylylcyclase in allosteric way and it increases cyclic 
guanosine monophosphate concentration leading to several cyclic GMP dependent 
responses. The cGMP-dependent action of NO are widespread and cGMP accounts for 
most of the physiological action of NO [45].  
In addition to its physiological roles NO also has pathophysiological actions; NO reacts 
with different oxygen species to form highly reactive molecules that can damage cellular 
components. First NO interacts with superoxide anions (O2-), which is usually generated 
during mitochondrial OXPHOS activity to generate peroxynitrate (ONOO-) which can in 
turn lead to cytochrome C release and blockade of mitochondrial complexes I and IV [46-
47]. ONOO-can also interact with cysteine residues to form S-nitrosothiols; this 
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modification is important for protein regulation but it can also cause protein dysfunction 
[48].  
Finally NO plays a role in glutamate excitotoxicity, under certain condition NO can block 
NMDA receptor by S-nitrosylation and protects from cell death [49], but in different 
situation it can enhance neuronal injury, increasing excitotoxicity effects [50] 
 
2.1 THE NITRIC OXIDE SYSTEM IN SKELETAL MUSCLE  
The role of NO in the regulation of skeletal muscle physiological activity, including 
excitation–contraction coupling, autoregulation of blood flow, calcium homeostasis and 
bioenergetics has been investigated extensively. All three NOS isoforms are expressed in 
skeletal muscle: nNOSis abundant at the surface of type II fibres (fast twitch), whereas it 
is less represented intype I (slow twitch) fibres[51], eNOS has been described in several 
muscles as a peripheral membrane protein, which is targeted to endothelial plasmalemmal 
caveolae through specific interaction with caveolin-1 and caveolin-3.Changes in the 
expression of these enzymes may occur in skeletal muscle: expression of nNOS is 
increased by crush injury, muscle activity and ageing [37];while nNOS is enhanced by 
chronic exercise and shear stress [52]. Conversely iNOS is absent or present at very low 
levels in skeletal muscles under physiological conditions, but its levels are upregulate 
when skeletal muscle is subjected to severe inflammatory conditions, such as in the 
course of autoimmune inflammatory myopathies and after crash injury[36]. 
 
 
 
Fig. 7 Exon structure of the murine Nos1 gene. The coding sequence is shown in gray, and asterisks 
mark translation initiation sites. The 5ʹ- and 3ʹ-untranslated sequences are shown as white boxes.  
 
Globally, skeletal muscle expresses three different alternative spliced isoform of 
nNOS:sarcolemmal nNOSµ, nNOSβ of Golgi apparatus and cytoplasmic nNOSγ[53]. In 
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mature skeletal and cardiac myocytes the majority of NOS activity is identified with 
nNOSµ, that contains a 34-aminoacid insert as a result of the alternative splicing of 
NOS1pre-RNA between exons 16 and 17 (figure 7). Evidences suggest that different 
nNOS splice variants creates functionally distinct NO signaling microdomains, with local 
action of NO. In fact the nNOS splice variant, localized to the Golgi complex, regulates 
microtubule cytoskeleton integrity and is a critical regulator of skeletal muscle fatigue 
and post exercise force output, sarcolemmal nNOSµ is involved in maintaining blood 
delivery during exercise, in modulating glucose homeostasis, controlling muscle mass 
and regulating fatigue resistance while function of cytoplasmic nNOSγ remains to be 
determined. 
Contraction-induced production of NO by sarcolemmal nNOSµ attenuates α-adrenergic 
receptor mediated vasoconstriction, thus maintaining appropriate blood and oxygen 
delivery to active muscles[54-56]. 
The localization of nNOSµ to the dystrophinglycoprotein complex at sarcolemma, is a 
key aspect that explains the coupling of NO generation with muscle contractile activity 
(figure 8).  
 
 
Fig 8 Model for nNOS splice variant microdomain signaling in skeletal muscle. 
 
NO exerts its effects in skeletal muscle by activation of NO-dependent guanylylcyclase 
with formation of cyclic GMP, inhibition of cytochrome c oxidase in the mitochondrial 
respiratory chain or S-nitrosylation, the covalent attachment of a nitrogen monoxide 
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group to the thiol side chain of cysteine. Cyclic GMP-dependent signalling plays a major 
role in NO-dependent vasodilation and vascular responses, and presides over complex 
intracellular cross-talk events involving calcium and sphingolipids, which are key players 
in muscle homeostasis [57-58]. In addition, cyclic GMP mediates the NO-dependent 
biogenesis of mitochondria, that occurs via activation of a pathway involving sirtuin 1, 
the peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC-1α), the nuclear 
respiratory factor 1, and the mitochondrial transcription factor A [59]. Inhibition of 
cytochrome c oxidase in mitochondria that occurs at physiological concentrations of NO 
is also particularly relevant in skeletal muscle. The third main mechanism of NO action, 
S-nitrosylation, regulates the activity of several enzymes that are important in skeletal 
muscle physiology among which are phosphatases, caspases and oxidoreductases[60-
64]as well as of several transcription factors, such as p53 and NF-kB[65-66].  
A significant contribution to regulation of NO concentrations in muscle, with 
consequence also on its bioenergeticsrole, comes from myoglobin that acts as a NO 
scavenger in skeletal muscle, thus regulating its delivery [67]. Myoglobinexpression is 
developmentally regulated in skeletal muscle, and its expression is higher in oxidative, 
fatigue-resistantfibres[68]. In myoglobin-deficient mice there is an increased 
compensatory stimulation of skeletal muscle NO generation, associated with other 
changes relevant to metabolism such as fibre type transition (type I to type II in the soleus 
muscle), increased expression of the hypoxiainducible factor 1 α, stress proteins such as 
heat shock protein 27, and the vascular endothelial growth factor that stimulates 
angiogenesis. 
 
2.2 NITRIC OXIDE IN MYOGENESIS AND SKELETAL MUSCLE  
Several studies in the last decade have shown that NO regulates the myogenic precursor 
cells through a variety of actions, mediated by different signal transduction pathways and 
downstream effectors. These various actions of NO converge in stimulating, on the one 
hand, the process of proliferation, activation and differentiation of these cells; on the 
other hand, in maintaining their reserve pool so that it does not become exhausted during 
physiological muscle damage. Such mechanisms involvingNOalso explain, at least in 
part, why NO may have therapeutic efficacy in pathologies, such as muscular 
dystrophies, where the muscle is subject to repetitive rounds of damage. 
NO is implicatedin activation of SC immediately upon damage regulating release of 
HGF, during skeletal muscle injury or stretchingand HGFis responsible for 
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triggeringactivation of quiescent satellite cells in vivo[69]. Reduced NOS activity 
prevents the increase in myogenic cells yield, when they areisolated from the injured 
muscle, and delays the activation of SC after isolation[70].Further, a single 
administration of NOS inhibitors in rats subjected to muscle trauma preventsthe increase 
of SC number[71] andshowsincreased levels of collagen, suggesting that blocking NO 
signal in the early phase of injury impairs muscle repair, favoring fibrotic scar tissue 
production. 
NO has beenfound to be crucial for the fusion of SC. Of importance, this effect is 
observed not only on adult SC but also on the presomitic mesoderm, further indicating 
that NO has an effect at critical stages of pre-postnatal muscle developmental life. In 
fact,differentiation of embryonic muscle cells involves fusion of mononucleated 
myoblasts into multinuclear myotubes. These myoblasts have NOS activity as measured 
by their ability to convert arginine to citrulline and NOS activity increases dramatically in 
cells competent for fusion but not in proliferating myoblasts (or in myotubes indicating 
that NOS activity in cultured myoblasts is critically dependent on time of 
differentiation[72]influencing myoblasts fusion.Moreover, the effect of NO on adult 
muscle appears of importance as it prevents the exhaustion of the SC pool in case of 
severe muscle damage, such as in muscular dystrophy. In this conditions, genetic ablation 
of nNOS in fibres or treatment with NOS inhibitors is sufficient to induce progressive 
reduction of the muscle regenerative capacity, confirming the obligatory role of NO in 
maintaining the myogenic precursor pool in vivo[73]. Finally, recently it has been 
described a role of NO in mitochondrial respiration biogenesis and dynamics, processes 
that have a role in myogenesis, in particular in differentiating myoblast prior to their  
fusion, thus NO exerts a quality control check on differentiation by regulating 
mitochondrial morphology and function. 
 
2.3 NO AND MITOCHONDRIA 
2.3.1 Mitochondrial structure and Dynamics 
Mitochondria are intracellular organelles (with a 0.5-1µm diameter) associated with the 
microtubules which define their distribution and localization in the different cell types, 
taking up variable portion of the cytoplasm. Mitochondria are organized into two 
sections, the matrix and the inter-membrane space, by means of two highly specialized 
membranes playing different functions: the Outer Mitochondrial Membrane, OMM and 
the Inner Mitochondrial Membrane (IMM). The OMM displays many copies of a carrier 
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protein called porin, which forms wide aqueous channels through the double 
phospholipidic layer. Ions and tiny molecules (up to a molecular weight of 5000 daltons) 
can easily enter into the mitochondria through these channels, thus reaching the inter-
membrane space where they are stored up. The inter-membrane space shows a chemical 
composition very similar to the cytosol, indeedthe matrix contains a well selected portion 
of molecules, because of the selective permeability of IMM. IMM and matrix are the 
functional areas of the mitochondria. IMM is a double phospholipidic layer composed by 
high amount of cardiolipin and no cholesterol. A further relevant feature is the abundance 
of proteins, correspondent to more than 80% of the IMM’s total composition. These 
proteins are involved in the energy conversion and in the synthesis of ATP, but also in the 
metabolite exchange through IMM.IMM is bent to build a number of folds, called cristae, 
which remarkably increase IMM surface and the efficiency in the ATP production. The 
number of cristae changes according to the cell type (figure 9). 
 
Figure 9 Mitochondria representation 
 
The mitochondrial matrix contains all the enzymes meant for the catabolism of the 
pyruvate and the fatty acids and all the enzymes of the Kreb’s cycle that oxidize the acetil 
CoA to generate reducing equivalents for the respiratory chain. Scattered inside are also 
ribosomes, tRNA and several copies (from 2 to 10) of mitochondrial DNA (mtDNA). 
Mitochondria have their own genoma and all that is required for transcription and 
translation processes. mtDNA codifies 37 genes, 13 of which correspond to complexes I, 
III, IV and V of the respiratory chain, while the others correspond to tRNA and rRNA.  
All the biochemical reactions of the mitochondria take place in the matrix and IMM. 
They generate CO2, H2O and ATP from the oxidation of the nutrients. Besides the 
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important role played in the oxidation of the substrates and in the ATP synthesis, 
mitochondria are involved in many other functions. In particular they control the 
intracellular homeostasis of Ca2+,the synthesis of a number of compounds ,apoptosis, cell 
cycle regulation, regulation of cellular redox state, heme and cholesterol synthesis and 
heat production. 
In order to suit the cells’ needs, mitochondria have the possibility to change their shape 
and function very quickly and these morphological changes are indicative of their 
function and their capacity of playing several roles.Mitochondrial morphology and 
number depend on the balance between two opposing processes, fusion and 
fission[74](Figure 10). 
 
 
Fig 10 Mitochondrial dynamics. 
 
Fusion of isolated mitochondria induces the formation of an extended interconnected 
mitochondrial network. This change enables mitochondria to mix their contents within 
the network resulting in the redistribution of metabolites, proteins and mtDNA. 
Moreover, fusion into a network is a selective process occurring preferentially between 
mitochondria with high mitochondrial membrane potential and however it generates a 
population of non-fusing mitochondria.. Conversely, mitochondrial fission or 
fragmentation is a mechanism that segregates components of the mitochondrial network 
producing depolarized mitochondria, with reduced expression levels of OPA1 and 
reduced size, moreover these mitochondria show less fusion capacity and they are 
removed by autophagy. Both mechanisms are evolutionarily conserved from yeasts to 
human. In mammals, mitofusin 1 (Mfn 1), mitofusin 2 (Mfn 2) and optic atrophy protein 
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1 (OPA 1) are required for fusion of both the outer and inner mitochondrial membrane. 
Both Mfn1 and Mfn 2 are integrated into the OMM and form homo- or hetero- oligomers 
which promote tethering and fusion of the OMMs from two different mitochondria. OPA 
1 is anchored to the IMM by a transmembrane domain at the N terminus but most of the 
protein is exposed to the intermembrane space. OPA 1 requires Mfn 1 to regulate 
mitochondrial fusion[75]and, oligomerization of OPA 1 regulates apoptosis by 
controlling cristae remodeling and cytochrome C release[76]. 
Mitochondrial fission depends on the GTPase cytosolic dynamin-related protein 1 (Drp1), 
which shows a cytosolic localization that after recruitment to the OMM and 
oligomerization forms sub-mitochondrial foci resulting inactive GTP-dependent 
mitochondrial fission sites[77]. 
Mitochondrial fusion, fission and mitochondrial turnover (the balance between 
mitochondrial biogenesis and degradation) are interconnected processes essential for 
mitochondrial quality control. Mitochondrial biogenesis is controlled by a family of 
coactivators including PGC-1α and PGC-1 β (peroxisome proliferator-activated receptor-
γ coactivator-1α and β). PGC1 family members are preferentially expressed in tissues 
with high- mitochondrial function like heart, adipose tissue and slow-twitch skeletal 
muscle. PGC-1 α coordinately increases mitochondrial biogenesis as well as the uptake 
and utilization of substrates for energy production, being crucial in the maintenance of 
energy homeostasis. PGC-1α is a powerful coactivator of NRF-1and NRF-2 enhancing 
the expression of mitochondrial transcription factor A (Tfam), mitofusins and of different 
nuclear genes encoding mitochondrial proteins. Both Tfam and nuclear gene products are 
imported into the mitochondria where they regulate the expression of mitochondrial 
proteins required for ATP synthesis[78]. 
 
2.3.2 Mitochondria in skeletal muscle 
Skeletal muscles are composed of myofibers which differ in mitochondrial content, 
physiological properties and myosin composition. The relative distribution of the 
different myofiber types accounts for the functional properties of muscles (figure 11). 
Muscles that rapidly generate a great force for a short time are mainly composed of 
glycolytic fibers, while muscles that produce discrete (lesser) force for prolonged periods 
are constituted mainly of oxidative fibers (rich in mitochondria). Depending on the 
frequency, intensity, duration and the type of exercise (resistance or endurance), different 
signaling pathways modulate changes in mitochondrial content, protein synthesis and 
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shifts in fiber type. For instance, endurance training induces mitochondrial biogenesis to 
improve fatigue resistance, resulting in a fast-to-slow fiber-type switch. Conversely, 
disuse or denervation causes the suppression of β-oxidative program and the conversion 
from slow oxidative fibers into fast ones[79-80]. 
During contraction, cytoplasmic calcium concentration transiently increases, as well as 
ROS production and ATP consumption. The alteration in calcium homeostasis activates 
calcium-sensitive signaling such as calcium/calmodulin-dependent protein kinases 
(CaMK) and calcineurin/NFAT pathways. 
 
 
 
Figure 11 An electron microscope image of skeletal muscle (25,000x) showing mitochondria (the 
organelle in a cell responsible for energy metabolism) within the myofibrillar area (responsible for 
muscle contractile function 
 
On the other side ATP depletion modifies the AMP/ATP ratio, activating the energy 
sensor AMP-activated protein kinase (AMPK). Both the calcium-dependent pathways 
and AMPK modulate the activity and the expression of PGC-1α[81]. 
In proliferating myoblasts, approximately 30% of the ATP used by the cells is provided 
by OXPHOS, whereas terminally differentiated myotubes rely on mitochondrial 
respiration as their major source of metabolic energy (approximately 60%). Intriguingly, 
the total metabolic rate remains constant throughout the culture period, but there is a 
steady shift toward a greater reliance on mitochondrial pathways[82]. Taken together, 
these findings suggest that a metabolic shift from glycolysis to oxidative phosphorylation 
as the major energy source takes place during myogenesis. 
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Recent studies have extended our knowledge of the potential role of mitochondrial 
biogenesis in muscle regeneration . It has been reported that muscle regeneration is 
impaired when mitochondrial protein synthesis is inhibited with chloramphenicol[83]. 
Chloramphenicol inhibits protein synthesis in mitochondria but not in mammalian 
cytoplasmic ribosomal systems. 
Chloramphenicol inhibits myogenic differentiation by downregulating Myogenin but not 
MyoD and Myf5[84]. Interestingly, this downregulation is commonly observed also with 
FCCP, myxothiazol, rotenone, and oligomycin[85], which affect mitochondria at 
different levels. These findings suggest that Myogenin could be an important target of 
mitochondrial activity. Chloramphenicol has no effect on Myogenin mRNA stability, 
suggesting that mitochondrial activity could regulate Myogenin expression at the 
transcriptional level [86]. 
Moreover study show that the muscle specimens analyzed at day 10 after initial freeze 
injury and injection of chloramphenicol at days 3, 5, and 7, have impairment of 
mitochondrial activity that results in poor muscle regeneration with small myofibers and 
increased connective tissues. Overall, this supports in vitro data showing that 
chloramphenicol blocks myogenic differentiation[87]. 
Understanding how mitochondria are involved in myogenesis will provide a valuable 
insight into the underlying mechanisms that regulate the maintenance of cellular 
homeostasis. Recently, it has been reported that the transgenic mice with skeletal 
musclesspecific expression of PGC-1preserve mitochondrial function as well as 
neuromuscular junctions and muscle integrity during ageing[88] and mitochondrial gene 
therapy may be effective in the treatment of muscle injury [89]. These efforts may 
facilitate to understand the molecular mechanisms of mitochondrial disorders in muscle. 
 
2.3.3 NO, mitochondria and muscle 
Mitochondria possess several hemoproteins (e.g. cytochrome c oxidase), thiols (e.g. 
glutathione) and cysteine-containing proteins, and they are major cellular sources of 
superoxide anion. Consequently, mitochondria are important targets of NO and contribute 
to several of the biological functions of NO. 
Some studies have revealed the presence of an NOS isoform on the mitochondrial inner 
membrane (mtNOS). Whose activity depends, typically, on Ca2+. Thus, increased intra 
mitochondrial Ca2+concentration [90] increases the activity of mtNOS, which in turn 
decreases both the mitochondrial consumption of O2and the mitochondrial 
26 
 
transmembrane potential (∆ψ).. Conversely, inhibiting the basal activity of mtNOS 
increases mitochondrial consumption of O2and ∆ψ. 
Characteristic property of NO is the ability to compete with O2;[3, 91-92] binding of NO 
to cytochrome c oxidase triggers intracellular signaling events including ROS generation 
with potentially hazardous consequences[93]. In particular increased NO concentration 
results in peroxinitrite production that, in turn, irreversibly inhibits complex I and II of 
the electron transport chain. 
Nitric oxide is a plausible regulator of mitochondrial biogenesis and can directly affect 
respiration in myocytes. Indeed, long-term exposure to NO triggers mitochondrial 
biogenesis in mammalian cells and tissues through the activation of guanylatecyclase and 
generation of cGMP. The NO/cGMP-dependent mitochondrial biogenesis is associated 
with enhanced coupled respiration and ATP content in skeletal muscle [3]. 
Nitric oxide interacts with the metabolic sensor enzyme, AMPK (Lira et al., 2007) and 
together they cooperate to regulate PGC-1a. The AMPKa1 isoform is identified as a 
mediator of NO-induced effects in skeletal muscle cells and the synergistic interaction 
with NOS is critical for maintenance of metabolic function in skeletal muscle[94]. 
Nitric oxide is also important to control mitochondrial shape and function and inhibition 
of NO synthesis in myogenic precursors enhanced the activity, translocation and docking 
to mitochondria of Drp-1, leading to inhibition of mitochondrial elongation. Under this 
condition, differentiating myoblasts displayed a latent mitochondrial dysfunction with 
impaired bioenergetics activity[5]. 
Also relevant is the role of NO produced by eNOS. Mice with quantitative reductions in 
eNOS expression (approximately 40%)display reduced expression of mitochondrial 
oxidative phosphorylation complexes, impaired ATP level and CaMKII phosphorylation 
in skeletal muscle. An acute exercise in vivo elicits a number of physiological processes 
that depend on eNOS expression with for instance the exercise-induced AMPK a 
phosphorylation being reduced in parallel with decrease in eNOS expression. Thus 
ablation of eNOS results in impaired exercise capacity, hypoglycemia, and increased 
plasma lactate levels without changing the mitochondrial content. However, effects of 
NO are rarely unidirectional and ultimately beneficial[95].  
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Chapter 3 AUTOPHAGY 
 
Autophagy is an evolutionarily conserved process whose primary task in lower organisms 
is the maintenance of metabolic homeostasis in the face of changing nutrient availability. 
In recent years, a growing number of functions have been attributed to autophagy, but 
almost all of them can be included in one of the following four categories: quality 
control, cellular source of energy, cell and tissue remodeling and cellular defense. The 
ability of different autophagic pathways to break down intracellular components (e.g., 
proteins, lipids, sugars, and nucleic acids) and recycle their constituent elements back to 
the cytosol makes it an ideal mechanism to supply cells with this elements when nutrients 
are scarce[96]. 
Double-membrane vesicles, termed autophagosomes, engulf long-lived proteins, 
damaged organelles, and even invasive pathogens, and transport these cargos to the 
lysosomes. There, the outer-membrane of the autophagosome fuses with the lysosomal 
membrane, and the inner vesicle, together with its cargo, is degraded. The resulting 
macromolecules can be recycled back to the cytosol for reuse during starvation [97]. This 
role in recycling is complementary to that of the ubiquitin-proteasome system, which 
degrades proteins to generate oligopeptides that are subsequently degraded into amino 
acids.  
Cargo recognition and delivery occurs by different mechanisms, depending on the type of 
cargo and the cellular conditions and giving rise to different modalities of autophagy 
(Figure 12) [98]. The best characterized in mammalian cells are [99]: 
• Chaperone-mediated autophagy (CMA): a targeting motif in the substrate 
proteins is recognized by a cytosolic chaperone that delivers it to the surface of 
the lysosome.  
• Microautophagy: the lysosomal membrane invaginates to trap regions of the 
cytosol that are internalized into the lysosomal lumen as single membrane 
vesicles.  
• Macroautophagy: a whole region of the cytosol is sequestered into a double 
membrane   vesicle that fuses with lysosomes for cargo delivery.  
These autophagic processes differ not only in terms of mechanistic and morphological 
characteristics but also in the factors involved. Among these types, macroautophagy 
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(hereafter autophagy) is the most comprehensively studied and best characterized 
process. 
 
 
Figure 12 Autophagic pathways. Cytosolic proteins can reach the lysosomal lumen for degradation via 
autophagy through three different mechanism (A) macroautophagy, (B) microautophagy, (C) chaperone-
mediated autophagy. 
 
 
 
3.1 MACROAUTOPHAGY 
Macroautophagy was first described in mammalian cells more than 50 years ago, but only 
in the past decade that the molecular basis for this process has been illuminated.  
The autophagy process is divided into mechanistically distinct steps, including: induction, 
cargo recognition and selection, vesicle formation, autophagosome-vacuole fusion, and 
breakdown of the cargo followed by release of the degradation products back into the 
cytosol (figure 13). These steps require energy and involve different sets of Atg 
(autophagy-related proteins) proteins [100]. The large majority of these proteins are 
conserved from yeasts to humans and can be divided into three different functional 
groups: Atg1-ULK1 kinase complex, required for the induction of autophagy, Atg6 and 
Atg14 are part of a phosphatidylinositol 3-kinase complex, required for vesicle nucleation 
and finally, two conjugation systems that are built around the ubiquitin-like proteins Atg8 
and Atg12 [101]. Orthologs of most of these yeast Atg proteins exist in complex 
eukaryotes. 
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Figure 13 Process of autophagy. The process of autophagy includes five steps: initiation, elongation, 
maturation, fusion and degradation.  
 
 
3.2 MOLECULAR MACHINERY OF AUTOPHAGY 
 
 3.2.1 Initiation and assembly of the initial phagophore membrane 
The membrane source from which autophagosomes arise is still a matter of debate, and 
there may be multiple sources. It has been hypothesized that autophagosomes can either 
be generated de novo from preexisting intracellular precursor molecules, or could arise 
from other intracellular membrane structures like the endoplasmic reticulum (ER) [102] . 
The formation of new autophagosomes requires the activity of the class III 
phosphatidylinositol 3-kinase (PI3K) and Vps34. Phosphatidylinositol-3-phosphate (PI-3-
P), the product of Vps34 activity, plays an essential role in the early stages of the 
autophagy pathway. Vps34 is part of the autophagy-regulating macromolecular complex 
(PI3K complex) consisting of Beclin 1/Atg6, Atg14/barkor, and p150/Vps15 [103]. The 
activity of Vps34 is enhanced by its interaction with Beclin 1 [104]. The function in 
autophagy of Beclin 1 binding partners is regulated by Bcl-2 (B-cell 
lymphoma/leukemia-2), an antiapoptotic protein. In fact, Bcl-2 binding and sequestering 
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Beclin 1 under nutrient-rich conditions inhibits autophagy and dissociation of Beclin 1 
from Bcl-2 is required for autophagy induction.  
A second macromolecular complex implicated in the initiation step of autophagosome 
formation is the [105] FIP200-ULK1/Atg1 complex [106-107]. Atg13 binds ULK1 or its 
homolog ULK2 and mediates their interaction with FIP200. Under nutrient deprivation 
conditions, Atg13 and ULK1/2 are dephosphorylated, thereby activating ULK1/2, which 
phosphorylates FIP200 to induce autophagosome formation. 
 
3.2.2 Autophagosome Formation/Elongation 
Unlike processes of vesicle formation in most endomembrane trafficking systems, 
double-membrane autophagosomes appear to be assembled at the pre-autophagosomal 
structure by addition of new membranes, thus, formation of the sequestering vesicles is 
likely the most complex step of autophagy. Multiple Atg proteins are recruited to the 
phagophore to participate in autophagosome formation, and this step requires the highly 
regulated coordination of all of these proteins. There are two protein conjugation systems 
necessary for autophagosome formation (figure14), the Atg12-Atg5 and the Atg8-
phosphatidyl ethanolamine systems [108]. The mechanism of both conjugation systems 
closely resemble ubiquitination reaction and the main difference between the two systems 
is related to the fate of the ubiquitin and ubiquitin-like proteins. While the ubiquitin 
proteasome pathway recycles ubiquitin molecules, the autophagy-lysosome system 
progressively loses the ubiquitin-like proteins, forcing the cell to replenish them in order 
to maintain the autophagic flux.  
 
 
Figure 11: Schematic representation of the autophagic conjugation system. 
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• Atg12 conjugation system 
Atg12 was the first ubiquitin-like Atg protein to be identified. In the canonical system, 
ubiquitin is synthesized as a precursor and is processed by a specific protease to expose 
the carboxy-terminal glycine residue. Activated by an E1 enzyme, ubiquitin is then 
transferred to an E2 enzyme, forming a thioester bond. An E3 ubiquitin ligase recognizes 
the target protein and transfers ubiquitin from the E2 to a lysine residue on the target.  
Analogous to ubiquitination, there is an E1-like enzyme, Atg7, and Atg12 is activated by 
forming a thioester bond between the C-terminal Gly 186 of Atg12 and the Cys 507 of 
Atg7 [109]. The ATP –binding domain of Atg7 is also homologous to the corresponding 
region in other E1 enzymes and is essential for the formation of the Atg12–Atg5 
conjugate. After activation, Atg12 is transferred to Atg10, which is an E2 enzyme, and is 
eventually conjugated to the target protein Atg5 [101]. Atg5 interacts further with a small 
coiledcoil protein, Atg16, and Atg12–Atg5-Atg16 forms a multimeric complex through 
the homo-oligomerization of Atg16 [110]. In addition, no processing enzyme has been 
identified that cleaves the isopeptide bond between Atg12 and Atg5, suggesting that this 
conjugation is irreversible.  
• Atg8 conjugation system 
The ubiquitin-like protein Atg8 is attached to phosphatidylethanolamine (PE) and the C-
terminal Arg 117 residue of Atg8 is initially proteolytically removed by a cysteine 
protease, Atg4, to expose Gly 116 [111]. This exposed glycine forms a thioester bond 
with Cys 507 of Atg7, which is also the site that participates in the Atg12–Atg5 
conjugation. Activated Atg8 is then transferred to the E2-like enzyme Atg3, also through 
a thioester bond. In the final step of Atg8 lipidation, Gly 116 of Atg8 is conjugated to PE 
through an amide bond[112]; Atg8–PE exists in a tightly membrane-associated form. 
Unlike Atg12–Atg5 conjugation, lipidation of Atg8 is reversible. Atg8–PE can be cleaved 
by Atg4 to release free Atg8 and it can still be used for another processes (Kirisakoet al., 
2000). In mammalian cells, several homologues of yeast Atg8 have been identified: 
MAP-LC3 (microtubule-associated protein light chain 3), GATE-16 (Golgiassociated 
ATPase enhancer of 16 kDa), GABARAP (γ-aminobutyric-acid-type- A-receptor-
associated protein). All of these undergo a modification process similar to that of their 
yeast counterpart, which is also catalysed by ATG4, ATG3 and ATG7 (Kabeyaet al., 
2004; Tanida et al., 2003; Tanida et al., 2006; Tanida et al., 2002; Tanida et al., 2001). 
Among them, MAP-LC3 (typically abbreviated LC3) has been best characterized as an 
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autophagosome marker in mammalian cells. LC3 is synthesized as proLC3, and ATG4B 
processes this precursor into LC3-I with an exposed C-terminal glycine (Kabeyaet al., 
2004). Catalysed by ATG7 and ATG3, cytosolic LC3-I is transformed to a membrane-
bound form, LC3-II, which corresponds to Atg8–PE in yeast. Because LC3-II remains on 
the inner membrane of autophagosomes until lysosomal enzymes degrade it, increased 
steady-state levels of LC3-II may be due to induction of autophagosome formation, a 
blockade in their maturation, or both.  
 
3.2.3 Vesicle fusion and autophagosome breakdown. 
When autophagosome formation is completed, Atg8 attached to the outer membrane is 
cleaved from PE by Atg4 and released back to the cytosol. Autophagosome- lysosome 
fusion is mediated by the same machinery that is involved in homotypic vacuole 
membrane fusion. In mammalian cells, the fusion event requires the lysosomal membrane 
protein LAMP-2 and the small GTPase Rab7 [113-114], although the mechanism is less 
characterized. 
After fusion, degradation of the inner vesicle is dependent on a series of 
lysosomal/vacuolar acid hydrolases, including proteinases A and B  and the lipase Atg15 
in yeast[115] and cathepsin B, D (a homolog of proteinase A), and L in mammalian cells 
[116]. The resulting small molecules from the degradation, particularly amino acids, are 
transported back to the cytosol for protein synthesis and maintenance of cellular functions 
under starvation conditions.  
 
3.3 SIGNALING PATHWAYS REGULATING AUTOPHAGY 
The complex molecular machinery of autophagy suggests that its regulation can be 
extremely complicated and may involve multiple signaling inputs. The classical pathway 
involves the serine/threonine kinase, mammalian target of rapamycin (mTOR) and, in 
recent years, are described various pathways and small molecules regulating autophagy 
via mTOR and mTOR-independent mechanisms. 
 
3.3.1 mTORPathway. 
One of the key regulators of autophagy is the target of rapamycin, mTOR kinase (figure 
15), which is the major inhibitory signal that shuts off autophagy in the presence of 
growth factors and abundant nutrients [117-118] . The presence of amino acids stimulates 
Vps34, which leads to mTOR activation and autophagy inhibition. mTOR activity 
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prevents the formation of Atg complexes including the Atg1-Atg13- Atg17 
serine/threonine protein kinase complex and the Vps34-Atg6-Vps15 lipid kinase complex 
[119]. It also interferes with the two ubiquitin-like conjugation systems of autophagy 
(Atg12-5 and Atg8). As a result, induction and expansion of the isolation membrane is 
abrogated. Conversely, TOR is inhibited during nutrient deprivation, inducing the 
autophagy machinery. Therefore, inhibition of TOR has been suggested to be necessary 
for the autophagy activation [120]. However it remains to be determined whether TOR 
inhibition is a universal mechanism for autophagy regulation. 
 
 
Figure 15 The phosphatidylinositol 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) pathway 
regulating autophagy 
 
3.3.2 Insulin/Growth Factor Pathways 
When growth factors are withdrawn from the extracellular milieu, in spite of sufficient 
nutrients, autophagy is induced and is indispensable for maintaining cellular functions 
and energy production [121]. In higher eukaryotes such as Drosophila and mammalian 
cells, the pathways through which hormones regulate autophagy are different from those 
of nutrients, but both converge on TOR (Figure 15). Insulin and insulin-like growth 
factors regulate mTOR through the class I PtdIns3K. Upon insulin binding, 
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autophosphorylation of the insulin receptor on tyrosine residues results in the recruitment 
and phosphorylation of IRS1 and IRS2 (insulin receptor substrate 1 and 2), which creates 
a docking scaffold that allows binding of adaptor proteins, including subunits of the class 
I PtdIns3K such as p85. Generation of PIP3 (phosphatidylinositol-trisphosphate) [122], 
by the class I PtdIns3K, increases membrane recruitment of both protein kinase B 
(PKB)/Akt and its activator PDK1 (phosphoinositide-dependent protein kinase 1), 
leading to phosphorylation and activation of PKB/Akt by PDK1 [123]. The 3 -
phosphoinositide phosphatase PTEN reverses PIP3 production, decreases the downstream 
PKB/Akt signaling and thus positively regulates autophagy.  
3.3.3 Energy Sensing  
During periods of intracellular metabolic stress, activation of autophagy is essential for 
cell viability, and the underlying pathways are understood in considerable detail. In 
mammalian cells, a reduced cellular energy (ATP) level is sensed by AMPK (5 -AMP-
activated protein kinase). AMPK is activated by a decreased ATP/AMP ratio through the 
upstream LKB1 kinase. Active AMPK leads to phosphorylation and activation of the 
TSC1/2 complex, which inhibits mTOR activity through Rheb [124]. Autophagy 
stimulated by mTOR downregulation results in elevated ATP production via recycling of 
nutrients. In addition, the LKB1-AMPK pathway phosphorylates and activates p27kip1, a 
cyclin-dependent kinase inhibitor leading to cell cycle arrest, which is essential to prevent 
cells from undergoing apoptotic death and to induce autophagy for survival in response to 
bioenergetic stress during growth factor withdrawal and nutrient deprivation [125].  
3.3.4 Stress Response  
Some of the other regulatory molecules that control autophagy include the eukaryotic 
initiation factor 2α (eIF2α), which responds to nutrient starvation, double-stranded RNA, 
and Endoplasmic Reticulum (ER) stress (figure16 A) [126]. 
Furthermore a common intracellular stress that effectively leads to induction of 
autophagy is the formation of ROS (figure 16 B). Mitochondria are the major source 
generating ROS, which will in turn damage these organelles. The link between ROS and 
autophagy induction may be the cysteine protease Atg4, which cleaves Atg8/LC3 from 
the autophagosome outer-membrane before, or soon after, autophagosome-lysosome 
fusion. It is not known, however, how ROS levels might be temporally and spatially 
controlled inside the cell, so that Atg4 can be locally activated to allow delipidation and 
35 
 
recycling of Atg8/LC3, or whether another mechanism is involved. In addition, Atg4 
seems to not be the sole molecule that underlies the oxidative regulation of autophagy.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16 (A) Autophagy regulation in response to stress, (B) Autophagy inductin by mechanisms 
sensing hypoxia or oxidative stress . 
 
3.3.5 The Ras/PKA pathway. 
The Ras/cAMP dependent protein kinase A (PKA) signaling pathway plays an important 
role in glucose sensing from yeast to mammals. In nutrient-rich conditions, the small 
GTPases Ras1 and Ras2 are active and enhance cAMP generation by the adenylyl cyclase 
and elevated cAMP levels inhibits PKA. Constitutive activation of the Ras/PKA pathway 
suppresses autophagy induced by mTOR inhibition in yeast [127-128], suggesting that 
the Ras-PKA pathway downregulates autophagy. 
Autophagy inhibition by Ras/PKA may be mediated through regulation of Atg1, which is 
identified as a phosphorylation substrate of PKA [127-128]. In the presence of nutrients, 
PKA phosphorylation causes Atg1 to be largely cytosolic and dissociated from the 
phagophore assembly site, whereas during starvation, Atg1 is dephosphorylated and 
localized to the assembly site.  
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3.4  MITOPAGY 
We use the term mitophagy to refer to mitochondrial degradation by autophagy [129] and 
is considered to be the central mechanism of mitochondrial quality and quantity control 
(figure 17). 
In mitochondria and sub mitochondrial particles as well as in intact cells, respiration 
produces reactive oxygen species (ROS) like H2O2 and superoxide anion and as a major 
source of ROS production, mitochondria are especially prone to ROS damage. Such 
damage can induce the mitochondrial permeability transition (MPT) caused by opening 
of non-specific high conductance permeability transition (PT) pores in the mitochondrial 
inner membrane. ATP depletion from uncoupling of oxidative phosphorylation then 
promotes necrotic cell death, whereas release of cytochrome c after mitochondrial 
swelling activates caspases and onset of apoptotic cell death [130].  
 
 
Figure 17 Scheme of mitophagy. 
 
Genetic evidence that autophagy is involved in mitochondrial degradation in mammals 
comes from characterization of the Atg7 conditional knockout mouse model [6]. The 
defect in autophagy is associated with an accumulation of deformed mitochondria in 
Atg7-deficient hepatocytes, suggesting that autophagy is involved in turnover of damaged 
mitochondria in mammalian cells [131]. 
In mammalian, two critical mediators of mitophagy are PTEN-induced putative kinase 1 
(PINK1) and Parkin (figure 18), encoded by genes in which loss of function mutations 
cause early onset autosomal recessive Parkinson disease.  
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PINK1 is a mitochondrial kinase that accumulates in damaged mitochondria and initiates 
the signal for translocation of the Parkin cytosolic E3 ubiquitin ligase specifically to 
damaged organelles [132]. Parkin-mediated ubiquitination of outer membrane proteins on 
these damaged mitochondria attracts autophagosomes, thus initiating mitophagy. 
Relocalization of Parkin from cytosol to mitochondria results in Parkin-mediated 
ubiquitination of dozens of outer mitochondrial membrane proteins, including mitofusin 1 
and mitofusin 2 [133]. Mitochondria engulfed by an autophagosome are transferred to 
lysosomes and degraded, which minimizes cellular toxicity from ROS that damaged 
mitochondria often produce and release. Interruption of PINK1-Parkin signaling disrupts 
mitophagy. 
 
 
Figure 18 The (PTEN)-induced putative kinase 1 (PINK1)-Parkin mechanism of mitophagy. 
 
Timely elimination of aged and dysfunctional mitochondria is essential to protect cells 
from the harm of disordered mitochondrial metabolism and release of proapoptotic 
proteins. For example, aging seems to affect mitochondria particularly because of 
mitochondrial ROS generation, protein damage occurs in mitochondria, and mutations of 
mtDNA accumulate.  
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3.5 AUTOPHAGY AND MUSCLE 
The role of autophagy in skeletal muscle has been investigated extensively [134] since is 
a peculiar mechanism when compared to other important metabolic tissues such as the 
liver and pancreas. During fasting, most tissues show a transient activation of autophagy 
that only lasts a few hours, while skeletal muscle shows a persistent generation of 
autophagosomes that continues for days [135]. During catabolic conditions, in skeletal 
muscle occur several changes: proteins are mobilized, mitochondrial and sarcoplasmic 
networks are remodeled and myonuclei are lost. In addition, the daily contractions can 
mechanically and metabolically damage/alter muscle proteins and organelles. Therefore, 
muscle cells require an efficient system for removing and eliminating unfolded and toxic 
proteins as well as abnormal and dysfunctional organelles (figure 19). Moreover skeletal 
muscle acts as a large store of protein that can be catabolized during nutrient deprivation 
or disease to provide free amino acids that can be used for protein synthesis in vital 
organs (i.e., heart, brain, lungs).  
 
 
Figure 19 Overview of signal transduction pathways controlling skeletal muscle autophagy. 
 
Thus, autophagy is crucial for normal muscle function and may contribute to muscle 
remodeling. However, aberrant protein degradation in the skeletal muscle is detrimental 
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for the economy of the body, and may cause myofiber dysfunction driving to muscle 
wasting and myopathy. 
To clarify the role of basal autophagy it was generated many model of knockout mice 
with muscle-specific inactivation of various genes coding for autophagy- related proteins, 
such as Atg7 or Atg5. Deletion of this genes causes altered muscle structure, with 
sarcomere disorganization and myofibers degeneration due to accumulation of protein 
aggregates, appearance of abnormal mitochondria and of concentric membranous 
structures that assemble between the myofibrils or just beneath the sarcolemma, induction 
of oxidative stress and activation of Unfolded Protein Response(UPR) [136] . Altogether, 
these effects accounted for muscle weakness, atrophy, and other signs of myopathy such 
as an irregular distribution of fibers’ shape as well as fibers with a vacuolated cytosol 
[137]. The fact that manipulation of animal models to dysregulate autophagy also leads to 
muscle pathology has prompted studies to investigate whether this process is altered in 
muscle diseases  [138]. 
Loss of muscle mass occurs in many conditions ranging from denervation, inactivity, 
microgravity, fasting to a multitude of systemic diseases [139] and in all of these 
catabolic conditions protein breakdown is enhanced and exceeds protein synthesis 
resulting in myofiber atrophy [140]. Also autophagosomes have been found in almost 
every myopathy and dystrophy studied so far and are characteristic of a group of muscle 
disorders named Autophagic Vacuolar Myopathies (AVM) [141] . 
The activation of the major proteolytic systems requires a transcription-dependent 
program and comparing gene expression in different models of muscle atrophy lead to the 
identification of a subset of genes that are commonly up- or down-regulated in atrophying 
muscle [142]. These common genes are thought to regulate the loss of muscle 
components and were thus designated atrophy-related genes or atrogenes [143]. The 
atrogenes comprise several proteasome subunits and two muscle specific E3 ligases, 
atrogin-1/MAFbx (muscle atrophy F box) and muscle RING finger 1 (MuRF1) [142]. 
The up-regulation of this atrogenes and several autophagy-related genes is normally 
blocked by Akt through negative regulation of Fork head box O (FoxO) transcription 
factors [143]. In particular, Akt regulates both the ubiquitin–proteasome system and the 
autophagy–lysosome pathway, and this action is mediated by FoxO transcription factors. 
In the presence of growth factors such as insulin or IGF, Akt phosphorylates and 
inactivates FoxO [144], promoting its export from the nucleus to the cytoplasm. The 
reduced activity of the Akt pathway observed in various models of muscle atrophy leads 
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to decreased levels of phosphorylated FoxO in the cytoplasm and a marked increase in 
nuclear FoxO.  
The translocation and transcriptional activity of FoxO members is sufficient to promote 
atrogin-1 and MuRF1 expression, and muscle atrophy. In addition to activating the 
transcription of the previously described atrogenes (including MRF1 and MAFbx), 
FoxO3 can induce expression of a number of autophagy-related genes including LC3, 
GABARAPl 1, Bnip3, Vps34, Ulk1, Atg12, and Atg4B in mouse muscle in response to 
fasting and denervation [21, 145]. Moreover, many genetic models have confirmed the 
role of autophagy during muscle atrophy (figure 20).  
 
 
Figure 20 FOXO-dependent protein breakdown and autophagy in skeletal muscle. 
 
For example, increased oxidative stress also been reported to occur during denervation 
and hind limb suspension. During these disuse conditions, neuronal NOS (nNOS) moves 
from the sarcolemma, where it is bound to the dystrophin-glycoprotein complex, to the 
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cytosol. Free cytosolic nNOS induces oxidative stress and enhances FoxO3-mediated 
transcription of the atrophy-related ubiquitin ligases, atrogin 1 and MuRF1, causing 
muscle loss [146].  
Recent data suggest that autophagy may also contribute to sarcopenia, the excessive loss 
of muscle mass that occurs in the elderly. During ageing there is also a progressive 
deterioration of mitochondrial function and activation of autophagy. Forced expression of 
PGC1a, the master gene of mitochondrial biogenesis, in skeletal muscles of old mice 
ameliorates loss of muscle mass and prevents the age-related increase of autophagy [88]. 
Thus, autophagy activation has been reported in acute conditions of muscle loss as well 
as in chronic and long-lasting situations of muscle debilitation and weakness. 
 
 
Fig A hypothetical diagram of the development of muscle-wasting diseases. The equilibrium of skeletal 
muscle autophagy is important for maintaining muscle mass and healthy skeletal muscle. An imbalance due 
to a number of factors such as diet, physical activity, systemic disease, or genetics can cause a shift in the 
autophagic flux 
 
Of interest, is the role of detective autophagy in different forms of inherited muscular 
disorders, including Limb girdle muscular dystrophy type 2B, Ullrich congenital 
muscular dystrophy, myositis, and Emery–Dreifuss muscular dystrophy has emerged in 
the past 5 years [147]. Deficient autophagy was also suggested to contribute to Duchenne 
muscular dystrophy (DMD) pathogenesis. The presence of swollen and damaged 
mitochondria, protein aggregation, and distension of sarcoplasmic reticulum, which are 
cyto-pathological hallmarks of DMD, are often observed when autophagy is impaired 
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[148]. In addition, activation of Akt was significantly higher in muscles from mdx mice 
and dystrophin-deficient primary myotubes, thereby suggesting a defective autophagic 
process. The causal relationship between DMD pathogenesis and dysfunctional 
autophagy has been investigated more recently in studies addressing this issue 
specifically [149].  
The beneficial effects of activating autophagy in mdx mice have been also confirmed by 
overexpressing peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1a), a 
transcriptional coactivator, which is a powerful mediator of muscle plasticity [150] and 
by pharmacological treatment with an agonist drug against the energy sensor AMPK, i.e., 
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) [151]. 
Therefore unbalanced autophagy might be the pathogenic mechanism (figure 21): at high 
levels, it can be detrimental and contribute to muscle atrophy; at low levels, it can cause 
weakness and muscle degeneration, due to the unchecked accumulation of damaged 
proteins and organelles [134, 147, 152]. Thus, a proper autophagic process is vital for 
both functional skeletal muscle, which controls the support and movement of the 
skeleton, and muscle metabolism [138]. 
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AIM OF THE PROJECT 
 
My phD project is divided in two sections: the formeris focused on the study of the 
relationship between the NO system, mitochondrial structure/activity and skeletal muscle 
wasting, paying attention on the role of autophagy and using a mouse model in which 
NOS1 (nNOSµ) is absent. My data demonstrate that an altered NO signaling leads to 
mitochondrial dysfunction resulting in enhanced autophagy and reduced muscle growth, 
however not associated with atrophy induction. Furthermore autophagy is essential to 
maintain muscle mass, but its role on regenerating population and its impact on muscle 
growth and development has not been evaluated yet. Starting form conclusion in the 
second part of my PhD project i focalized my attention on the role of autophagy 
specifically on satellite cells population, generating a transgenic mice in which autophagy 
is selectively inhibited in satellite cells and studying their impact on muscle growth. My 
data suggest that autophagy is involved in the controlling of satellite cells functions. 
Autophagy loss of function in satellite cells impairs their proliferation rate as well as their 
capability to fuse and differentiate. 
The study of these two different transgenic mice reveals as in muscle, unbalanced 
autophagy from the early phase of growth affects satellite cells population causing 
muscle wasting and suggests how during skeletal muscle development is important to 
have appropriate levels of autophagy 
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Materials and Methods 
 
Animals 
NOS1-/- mice homozygous for targeted disruption of the nNOS gene (strain name 
B6129S4- NOS1tm1Plh/J) were purchased from Jackson Laboratories (Bar Harbor, 
Maine, USA) (stock no. 002633). In this mouse model, targeted deletion of exon 2 
specifically eliminates expression of nNOSµ [37]. NOS1-/- mice were crossed with the 
wild-type B6129 strain to maintain the original background and to obtain a colony of 
NOS1-/- mice and wild-type littermate controls, with genotyping performed by tail 
clippings. Experiments were performed on male mice at postnatal day 10 (P10) and P120. 
C57BL/6 wildtype mice (strain name C57Bl10SnJ) were purchased from Charles River 
(Calco, Italy).  
To generate mice with specific Atg7 gene deletion in satellite cell population we crossed 
Atg7-floxed mice (Atg7 f/f) (generously provided by Sandri’s lab) with a transgenic line 
expressing Cre recombinase under control of Pax7 gene promoter (generously provided 
by Pura’s lab)[6]. Experiments were performed on male mice at postnatal day 21 (P21). 
Genotyping of mice Atg7-/- by PCR was performed by tail clippings with the following 
two primers:   
REV:5-TGGCTGCTACTTCTGCAATGATGT-3  
FW:5-CAGGACAGAGACCATCAGCTCCAC-3. 
Animals were housed in a regulated environment (23 ± 1°C, 50 ± 5% humidity) with a 
12-hour light/dark cycle (lights on at 08.00 a.m.), and provided with food and water ad 
libitum. For specific experiments, mice were killed by cervical dislocation. All studies 
were conducted in accordance with the Italian law on animal care N° 116/1992 and the 
European Communities Council Directive EEC/609/86. The experimental protocols were 
approved by the Ethics Committee of the University of Milano. All efforts were made to 
reduce both animal suffering and the number of animals used. 
 
Protein isolation and western blotting 
Satellite cells were harvested and homogenised for 10 minutes at 4°C in RIPA lysis 
buffer, containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 1% sodium 
deoxycholate, 1 mM EDTA and 0.1% sodium dodecyl sulphate (SDS). Tissue samples 
from muscles were homogenized in a lysis buffer containing 20 mM Tris-HCl (pH 7.4), 
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150 mM NaCl, 1% Triton X-100, 10% glycerol, 10 mM EGTA and 2% SDS. Buffers 
were supplemented with a cocktail of protease and phosphatase inhibitors (cOmplete and 
PhosSTOP; Roche). Protein concentration was determined using the bicinchoninic acid 
assay (ThermoFisher Scientific). Using published protocols[156], SDS and β-
mercaptoethanol were added to samples before boiling, and equal amounts of proteins (40 
µg/lane) were separated by 4% to 20% SDS-polyacrylamide gel electrophoresis 
(Criterion TGX Stain-free precast gels and Criterion Cell system; Bio-Rad). Proteins 
were then transferred onto a nitrocellulose membrane using a Bio-Rad Trans-Blot Turbo 
System. The membranes were probed using the following primary antibodies as indicated 
in the text: rabbit polyclonal anti-MyoD (C-20) (Santa Cruz Biotechnology, Dallas, TX, 
USA), rabbit polyclonal anti-Atg7 and rabbit polyclonal anti-LC3B (Sigma-Aldrich, 
Saint Louis, MO, USA), mouse monoclonal anti-sarcomeric myosin (MF20) 
(Developmental Studies Hybridoma Bank, Iowa City, IA, USA). 
After the incubation with the appropriate horseradish-peroxidase-conjugated secondary 
antibody (Cell Signaling Technology), bands were visualised using the Bio-Rad Clarity 
Western ECL substrate with a Bio-Rad ChemiDoc MP imaging system. To monitor for 
potential artefacts in loading and transfer among samples in different lanes, the blots were 
routinely treated with the Restore Western Blot Stripping Buffer (ThermoFisher 
Scientific) and reprobed with rabbit polyclonal anti-calnexin (GeneTex, Irvine, CA, 
USA), goat polyclonal anti-actin (I-19) or mouse monoclonal anti-vinculin primary 
antibodies (Sigma-Aldrich, Saint Louis, MO, USA). 
 
Real-time quantitative PCR 
Satellite cells and muscle tissue samples were homogenised, and RNA was extracted 
using the TRIzol (Invitrogen-Life Technologies, Monza, Italy). Using published 
protocols [159], after solubilisation in RNase-free water, first-strand cDNA was 
generated from 1 µg of total RNA using the ImProm-II Reverse Transcription System 
(Promega). As show in Table 1, a set of primer pairs amplifying fragments ranging from 
85 to 247 bp was designed to hybridise to unique regions of the appropriate gene 
sequence. Real-time quantitative PCR (qPCR) was performed using the SYBR Green 
Supermix (Bio-Rad, Hercules, CA, USA) on CFX96 Real Time System. All reactions 
were run in duplicate. A melt-curve analysis was performed at the end of each experiment 
to verify that a single product per primer pair was amplified. As a control experiment, gel 
electrophoresis was performed to verify the specificity and size of the amplified qPCR 
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products. Samples were analysed using the Bio Rad CFX manager software and the 
second derivative maximum method. The fold increase or decrease was determined 
relative to a calibrator after normalising to 36b4 (internal standard) through the use of the 
formula 2-∆∆CT [160]. 
 
Table 1 Primer pairs designed for qPCR analysis 
Name/symbol  Forward primer Revers primer 
Atrogin-1 (fbxo32) 5′-GCAAACACTGCCACATTCTCTC-3  5′-CTTGAGGGGAAAGTGAGACG-3 
MuRF1 (Trim63)  5′-ACCTGCTGGTGGAAAACATC-3′ 5′-CTTCGTGTTCCTTGCACATC-3′ 
Atg4b  5′-ATTGCTGTGGGGTTTTTCTG-3′ 5′-AACCCCAGGATTTTCAGAGG-3’ 
Bnip3  5’ -TTCCACTAGCACCTTCTGATGA-3′ 5′-GAACACGCATTTACAGAACAA-
3′ 
p62 (Sqstm1) 5′-GAAGCTGCCCTATACCCACA-3′ 5′-AGAAACCCATGGACAGCATC-3′ 
MyoD 5’GACAGGACAGGACAGGGAGGAG GGAGTGGCGGCGATAGAAGC 
Myogenin 5’GACCCTACAGACGCCCACAATC ACACCCAGCCTGACAGACAATC 
 
Primary myogenic cell cultures, immunofluorescience, fusion index and 
proliferation assay 
Using published protocols [5], myogenic precursor cells (satellite cells) were freshly 
isolated from muscles derived from the NOS1-/- mice, Atg7-/- mice and wild-type 
littermate controls.  
Briefly, hind limb muscles were digested with 2% collagenase-II and dispase for 10 
minutes at 37°C with gentle agitation. Contamination by non-myogenic cells was reduced 
by pre-plating the collected cells onto plastic dishes where fibroblasts tend to adhere 
more rapidly. Dispersed cells were then resuspended in Iscove’s modified Dulbecco’s 
medium supplemented with 20% foetal bovine serum, 3% chick embryo extract (custom 
made), 10 ng/ml fibroblast growth factor, 100 U/ml penicillin, 100 µg/ml streptomycin 
and 50 µg/ml gentamycin, and plated onto matrigel-coated dishes. Primary myoblasts 
were cultured in grow media to reach 80% confluence and switched into “differentiation 
medium” (Iscove’s modified Dulbecco’s medium supplemented with 2% horse serum 
and the antibiotics) for up to 48 hr. 
For immunofluorescence analysis cells were fixed using 4% paraformaldehyde for 10 
min at RT, permeabilized (0.1% Triton X-100 PBS) and incubate in blocking solution 
(PBS, 10% goat serum) (1hr RT). Cells were then incubated with an anti Myosin heavy 
chain primary antibody (MF20 ibridoma bank) diluted in blocking solution (2hr RT), then 
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washed in PBS, and incubated in fluorescent secondary antibodies  (1 hr RT). Nuclei 
were counterstained with DAPI solution. 
The fusion index is defined as the total number of nuclei in MF20-positive cells divided 
by the total number of nuclei per field. The number of nuclei per myotube was 
established counting nuclei within every myotube per microscopic field divided by the 
number of myotubes in the field, where a myotube is defined as a MF20-positive cell 
with at least two nuclei.Proliferation was assessed on cells grown on p60 dish using the 
CytoTrack Cell Proliferation Assay Kits (Bio-Rad) and assayed after 24 and 48h of 
proliferation counting the percentage of positive cells onto the Integrin α7+  population  
by flow cytometry. 
 
Facs analisis 
To determine the percentage of satellite cells resident in muscle, 80 mg of hind limb 
muscles were minced and digested with 0.2% of Collagenase II (Worthington 
Biochemical, Lakewood, NJ) following published protocols [161].  
For FACS analysis cells were stained with the following antibodies: anti-CD31-
phycoerythrin (PE)/Cy7 (PECy7, clone 390), anti-CD45-PECy7 (clone 30-F11) 
(eBioscience, Inc., San Diego, CA), anti-α7-Integrin-PE (AbLab, UBC Antibody Lab, 
Vancouver, Canada), anti-LY-6A/E SCA-1-allophycocyanin/Cy7 (APC/Cy7, clone B7, 
BD Biosciences, Franklin Lakes, NJ). Satellite cells were selected through flow 
cytometry as Integrin α7+/CD34+ double positive cells and CD45, CD31, CD11b, Sca1 
negative (Lin−) cells (Integrin α7+/CD34+/Lin−). 
 
Single-Fiber Culture Assays.  
Single floating myofibers were prepared from the gastrocnemius of 21 days-old Atg7-/- 
mice and controls, as described [162]. 
Individual intact myofibers were cultured in proliferating medium (20% fetal bovine 
serum [Mediatech, Herndon, VA], 10% HS, 2% CEE in DMEM) for 3 days and then 
fixed in 4% paraformaldehyde (PFA) for 10 min at room temperature. For 
immunoflurescence analysis fibres were permeabilized 4 min RT in 0.2% PBS/0.2% 
Triton X-100 [PBST]), incubated in blocking solution (BSA; 10% goat serum, PBS) for 
30 min RT and hybridated with primary antibodies (diluted in blocking solution) 
overnight at 4C. 
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The day after, single fibers were washed in PBS, incubated with appropriate flurescent 
secondary antibodies (diluted in blocking solution) and DAPI 1 hr RT. After several 
washes in PBS, single fibers were mounted and observed at fluorescence microscopy. 
The antibodies used in this study are: anti MyoD antibody (1:50; Dako E3238 or Santa 
Cruz Biotechnology), anti Pax7  antibody[1:10; Developmental Studies Hybridoma Bank 
(DSHB)] and Ki67 antibody  (1:250; Abcam ) . 
 
In vivo imaging using two-photon confocal microscopy 
Mitochondrial morphology and autophagosome formation in living animals were 
monitored in tibialis anterior muscles transfected by electroporation with plasmids 
encoding pDsRed2-Mito or the LC3 protein fused to the yellow fluorescent protein (YFP-
LC3), as described previously [143, 145, 153]. Two-photon confocal microscopy in the 
live, anaesthetised animals was then performed 12 days later on in situ exposure of 
transfected muscles. To allow the muscle to recover from the injection-induced swelling, 
microscopic observation was interrupted for two to five minutes.  
 
Transmission electron microscopy 
Tibialis anterior muscles were dissected and fixed for one hour in a solution containing 
4% paraformaldehyde and 0.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, 
immobilised on a Nunc Sylgard coated Petri dish (ThermoFisher Scientific, Waltham, 
MA, USA) to prevent muscular contraction as previously described [154]. The muscles 
were rinsed in the same buffer and dissected further into small blocks that were 
subsequently processed for transmission electron microscopy (TEM) as described 
elsewhere [155]. Briefly, the samples were postfixed with osmium tetroxide (2% in 
cacodylate buffer), rinsed, en bloc stained with 1% uranyl acetate in 20% ethanol, 
dehydrated and embedded in epoxy resin (Epon 812; Electron Microscopy Science, 
Hatfield, PA, USA) that was baked for 48 hours at 67°C. Thin sections were obtained 
with a Leica ultramicrotome (Reichert Ultracut E and UC7; Leica Microsystems, 
Wetzlar, Germany) stained with uranyl acetate and lead citrate, and finally examined with 
a Philips CM10 TEM (Philips, Eindhoven, The Netherlands). Morphometric analysis of 
mitochondrial cristae complexity was evaluated with a stereological method. Briefly, a 
regular grid has been superimposed over 10500X TEM micrographs and the number of 
intersections between the grid and mitochondrial cristae was recorded. The same grid was 
used for all the different analysis. 
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Confocal microscopy of myogenic precursor cells 
Cells were plated in eight-well Nunc LabTeck Chamber slides (ThermoFisher Scientific). 
When indicated cells were transfected with YFP-LC3 plasmid. Transfections were 
performed with the Lipofectamine LTX with Plus reagent (Invitrogen-Life Technologies) 
according to the manufacturer’s instructions. The cells were used 24 hours after 
transfection in the various experimental settings described. For confocal imaging, the 
cells were fixed in paraformaldehyde and washed in phosphate-buffered saline [157]. To 
prevent nonspecific background, cells were incubated in 10% goat serum/phosphate-
buffered saline followed by probing with the primary antibody mouse monoclonal anti-
cyclophillin D (Abcam). Cells were then incubated with the secondary antibody, Alexa 
Fluor 546 dye-conjugated anti-mouse IgG (Molecular Probes-Life Technologies, Monza, 
Italy). Slides were placed on the stage of a TCS SP2 Laser-Scanning Confocal 
microscope (Leica Microsystems) equipped with an electronically controlled and freely 
definable Acousto-Optical Beam Splitter. Images were acquired with x63 magnification 
oil-immersion lenses. Analyses were performed using Imagetool software (Health 
Science Center, University of Texas, San Antonio, TX, USA). Images of cells expressing 
YFP-LC3 were thresholded by using the automatic threshold function. 
 
Muscle immunohistochemistry and histology 
The tibialis anterior (TA) of nNos  mice and wild-type littermate controls at P10, P30 and 
P120 and tibialis anterior of Atg7-/- mice and wild-type littermate controls at P21 were 
removed, the proximal extremity fixed on a piece of cork with tragacanth gum and frozen 
in isopentane 
Serial 7 µm cryosections were cut with a cryostat and samples were stored at -80°C.  
For histological analyses, serial muscle sections were obtained and stained with 
Haematoxylin and Eosin (H & E), performed as previously described [149, 158]. The 
number of fibres was counted and analysed using the ImageJ software  
To measure the cross sectional area (CSA) of myofibres, muscle sections were stained in 
immunoflurescence with an anti-laminin A (a cell-adhesion molecule strongly expressed 
in the basement membrane of skeletal muscles) antibody (L1293; Sigma-Aldrich 
diluizione?)and an appropriate fluorescent secondary antibody. Morphometric analyses 
were performed on sections collected from similar regions of each muscle, using a Leica 
DMI4000 B automated inverted microscope equipped with a DCF310 digital camera. 
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Image acquisition was controlled by the Leica LAS AF software. The ImageJ software 
was used to determine the CSA of 1,000 to 3,000 individual fibres from at least two 
different fields for each muscle section. Four to nine sections from each muscle were 
analyzed.  
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RESULTS 
nNOSµ deficiency affects mitochondrial network remodelling, and autophagy 
NO is an important factor for muscle homeostasis; in vitro indications on cell lines and 
primary cells show that NO is able to modulate autophagy [147] and mitochondria 
morphology [2] both processes involved in the maintenance of muscle mass preventing 
muscle wasting[134, 147].The major source of NO in muscle is the neuronal NOS 
(NOS1)localized in the sarcolemma and associated with the dystrophin glycoprotein 
complex (DGC), thus to assess in details the role of NO in vivo on muscle, we studied the 
NOS1 knockout mice (NOS1-/-). In order to identify the changes in mitochondrial 
network morphology, tibialis anterior muscles of P120 NOS1-/- and wild-type control 
mice were imaged using pDsRed2-Mito, a mitochondrially targeted red fluorescent 
protein, by in situ two-photon confocal microscopy[143, 145, 153]. NOS1-/- mice 
showed a disorganized mitochondrial network (Fig. 1A). Accordingly, ultrastructural 
analyses by TEM revealed changes in the subsarcolemmal mitochondria of tibialis 
anterior muscles of NOS1-/- mice that exhibited, in thin sections, a significant increase in 
mitochondrial surface area (Fig 1B) and a significant decrease in the density of the cristae 
(Fig. 1C), as compared with the controls. The analysis of intermyofibrillar mitochondria 
showed a pattern of enlarged mitochondria indicating that the presence of these 
mitochondrial alterations in NOS1-/- mice muscle is not restricted to the sarcolemma but 
is a more general phenomenon.We then analysed autophagy a downstream process linked 
to mitochondrial stress: the two-photon confocal microscopy of the YFP-LC3 revealed 
the presence of LC3- positive vesicles, an established marker of autophagosome 
formation[163] in tibialis anterior muscles of P120 NOS1-/- mice (Fig. 1D). Furthermore, 
TEM analysis showed the presence of autophagic vacuoles and multivesicular bodies, 
indicative of an active autophagic pathway [164] (Fig 1B). The enhanced autophagy in 
the absence of NOS1 in skeletal muscle was confirmed by Western blot analysis. The 
appearance of a faster migrating band of LC3 protein due to its lipidation and cleavage is 
a common marker of autophagy induction [163]. As shown in figure 1E, tibialis anterior 
muscles of P120 NOS1-/- mice exhibited increased lipidated LC3 levels when compared 
to control mice.  
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Figure 1  Mitochondrial morphology and autophagy in skeletal muscles of NOS1-/- miceTibialis anterior 
muscles were isolated from wild-type and NOS1-/- mice at P120. (A) In vivo imaging of the mitochondrial 
network by two-photon confocal microscopy. Scale bar: 10 µm. (B) TEM images detecting the presence of 
abnormal, enlarged subsarcolemmal mitochondria (asterisks) or autophagic vacuoles (arrowheads) in 
NOS1-/- muscles. The inset depicts a multivesicular body in NOS1-/- fibres taken at higher magnification. 
(C) Subsarcolemmal mitochondrial ultrastructure analysis by TEM (D) In vivo imaging of autophagosome 
formation by two-photon confocal microscopy. Scale bar: 10 µm. (E) Western blot analysis of LC3 
lipidation. 
 
nNOSµ deficiency affects muscle growth 
We evaluated the effects of the absence of neuronal NOS on skeletal muscle phenotype.  
Since the body weight and the visceral adipose tissue of NOS1-/- male (figure 2A and 
2B) mice were significantly lower than wild-type control [54] we calculated the muscle 
size relative to body weight..As shown in Figure 2C, the relative mass of the muscles for 
the P120 NOS1-/- mice was significantly lower than the relative mass of the muscles for 
the control mice. This excludes the possibility that the changes in muscle mass are simply 
due to an overall change in the size of the mice. The overall morphology of the tibialis 
anterior muscle in P120 NOS1-/- mice was normal, without pathological features of 
necrosis, macrophage infiltration and centronucleatedfibres(Figure 2D). In addition, the 
number of fibres in tibialis anterior muscles was comparable in both NOS1-/- and control 
mice (Figure 2E). 
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Figure 2 Skeletal muscle phenotype of wild-type and NOS1-/- mice at P120. (A)Body weight of mice (B) 
Weight of visceral adipose tissue (C) Weight of tibialis anterior and gastrocnemius muscles. The muscle 
size is relative to body weight. (D) Histological sections of tibialis anteriorstained with H & E. Hematoxylin 
and eosin staining (E) The number of myofibres in tibialis anterior.  
 
By contrast, laminin staining of tibialis anterior, used to identify individual muscle fibers, 
revealed a significant decrease in the mean CSA of tibialis anterior sections in P120 
NOS1-/- mice when compared with control (Figure 3A, B and C). 
The examination of multiple time points was then carried out in order to establish a 
possible link between the changes in mitochondrial homeostasis and the reduction in 
muscle size. The CSA of hind limb muscle fibers were also significantly decreased at P10 
(figure 3D-F), P30 in NOS1-/- mice (figure 3G-I) when compared with the respective 
control.Using NOS1-/- mice it has been previously shown that neuronal NOS modulates 
the mechanism of disuse-induced atrophy via FoxO transcription factors [146]. 
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Figure 3 Muscle size during development(A-C-D) Laminin staining in tibialis anterior of wild-type and 
NOS1-/- mice at P120, P30, P10 respectively. (B-D-F) Representative distribution of CSA values and (C-F-
I) quantification of CSA in tibialis anterior of wild-type and NOS1-/- mice at P120P30, P10 respectively. 
 
However, the observation that CSA was always reduced at any time points considered, 
together with the observation that at different time points NOS1-/- and control mice 
expressed similar levels of transcripts encoding the classical atrogenesAtrogin-1 and 
MuRF1 (figure 4A-C)[165], indicates that the atrophy pathways do not play a key role in 
the development of NOS1-/- muscles. Muscle growth during post-natal development (P0 
to P21), but not at later stages, is accompanied by a continuous increase in the number of 
myonuclei resulting from satellite cell fusion[166]. 
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Figure 4 Analysis of atrophic pathways during muscle development in NOS1-/- mice.qPCR analysis of 
mRNA levels for atrogin-1and muRF1 in hind limb muscles of wild-type and NOS1-/- mice at P120(A) 
P30(B) and P10(C). Values are expressed as the fold change over wild-type.  
 
As shown in Figure 5A, NOS1-/- cells exhibited lower number of myonuclei inside the 
fibers at p10 suggesting defects in the proliferation and fusion of satellite cells. In 
agreement with this, levels of myosin and MyoD, which are markers of myogenic 
differentiation, were reduced in NOS1-/- satellite cells as compared to control cells 
(Figure 5B). Interestingly, CycloD staining of differentiating myogenic precursor cells 
confirmed that the absence of NOS1 induces diffuse mitochondrial fragmentation (Figure 
5C) as previously described [5]2010.  
 
Figure 5 Satellite cells defects in NOS1 -/- mice. (A) Confocal microscopy imaging of satellite cells 
isolated from wild-type and NOS1-/- mice and differentiated for 48 hours. Mitochondrial morphology was 
detected by mitochondrial matrix-specific protein cyclophillin D staining. Scale Bar: 10 µm. (B) Western 
blot analysis of myosin (MF20) and MyoD expression in satellite cells isolated from wild-type and NOS1-/- 
mice and differentiated for increasing times (C) Number of myonuclei per fibre in hind limb muscles.  
 
Taken together, our data argue that the absence of NOS1in muscle form the beginning 
induces mitochondrial fragmentation, activates autophagy and results in a deficit in 
satellite cell fusion/differentiation, thus impairing fibers growth . Furthermore NOS1-/- 
mice could be considered a model of skeletal muscle wasting due to high autophagy 
induction and affecting satellite cells pool. 
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NO signaling regulates autophagy machinery 
Activation of the NO-dependent enzyme guanylatecyclase, with formation of cyclic 
guanosine monophosphate (cGMP) and activation of a variety of downstream signaling 
cascades, including cGMP-dependent-protein kinases (PKG), contributes significantly to 
mediate the physiological effects of NO in muscle [154]. 
We analyzed the expression of relevant markers of the autophagic signaling pathway, 
namely LC3, by western blotting and p62, Bnip3 and Atg4 by qPCR analysis L-NAME, 
ODQ and KT5823 treatments increased lipidated LC3 conversion in differentiated 
satellite cells and LC3 lipidation induced by L-NAME and ODQ was blocked by DETA-
NO or 8Br-cGMP, respectively (Figure 6A). In addition, cells treated with L-NAME, 
ODQ and KT5823 expressed higher levels of transcripts encoding p62, Bnip3 and Atg4 
(Figure 6B). 
As shown by confocal microscopy fluorescence analysis of LC3 and the mitochondrial 
matrix-specific protein cyclophillinD (Figure 6C), in control cells LC3 staining was 
diffuse and the majority of mitochondria were in the elongated form, indicating myogenic 
differentiation and a low rate of autophagy. L-NAME, ODQ, and KT5823 treatment, 
while inducing mitochondrial fragmentation, resulted in LC3 localization into dot 
cytoplasmic structures, as compared to the diffuse cytoplasmic distribution observed in 
control cells. The effects of L-NAME and ODQ were prevented by DETA-NO and 8Br-
cGMP,respectively. Taken together these experiments recapitulate the results obtained 
with NOS1-/- satellite cells confirming the induction of autophagy associated with 
mitochondria fragmentation with a cGMP dependent pathway. 
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Figure 6 NO signalling and autophagic pathway in satellite cells. (A) Western blot analysis of LC3 
lipidation in cells differentiated for six hours in the absence or in the presence of L-NAME (6 mM), ODQ 
(10 µM), KT5823 (1 µM), L-NAME + DETA-NO (80 µM), and ODQ +8 Br-cGMP (2.5 mM). (B) qPCR 
analysis of mRNA levels for p62, Bnip3 and Atg4 in cells differentiated for six hours in the absence 
(control) or in the presence of L-NAME ODQ, and KT5823. (C) Confocal microscopy imaging of cells 
transfected with YFP-LC3. Mitochondrial morphology was detected by mitochondrial matrix-specific 
protein cyclophillin D (CypD) staining. Scale Bar: 10 µm.  
 
So far these data demonstrate that an altered NO signaling in myogenic precursor cells 
leads to mitochondrial network fragmentation and increased autophagy induction 
resulting in significant defects in myogenesis process both in vivo and in vitro, 
decreasing muscle development and leading to muscle wasting. 
Autophagy is essential to maintain muscle mass[136] but its role on regenerating 
population and its impacton muscle growth and development has not been evaluated yet. 
We have evidences from the NOS1-/- mice, described above, that high autophagy 
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induction impaired satellite cells population, however a better model to study this aspect 
is required. 
 
Generation of Muscle-Specific Atg7 Knockout Mice 
To investigate the physiological roles of autophagy in satellite cells population and its 
impact in muscle growth, we crossed Atg7-floxed mice (Atg7 f/f) [6] with a transgenic 
line, expressing Crerecombinase, under the control of Pax7 promoter the best 
characterized marker of satellite cells, in order to generate mice with specific Atg7 
deletion in the satellite cell population , which are hereafter referred to as Atg7-/-.  
In figure 7A was shown the schematic representation of the generation of Atg7f/fmice 
while the results of PCR genotyping were shown in figure 7B . 
 
Figure 7: Generation of Atg7f/f mice. (A)Schematic representation of the targeting vector and the 
targeted allele of Atg7 gene. (B) Genotyping from genomic DNA of the Atg7f/f mice.  
 
Efficient and specific inhibition of autophagy in gastrocnemius skeletal muscles(Figure 
8A) and satellite cells (Figure 8B) was confirmed by deletion of ATG7 and suppression 
of LC3 lipidation and  in whole protein extracts.LC3 exists in two forms and the absence 
of LC3II band confirmed that the reaction of LC3 conjugation to phospholipids was 
completely blocked, inhibiting the formation of autophagosomes. 
Conversely, Atg7 expression was unaffected in other tissues, such as brain liver lung and 
kidney (Figure 8C). Altogether, these findings validate our genetic mouse model of 
specific autophagy inhibition in muscle and satellite cells 
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Figure 8(A)ATG7 expression and impaired LC3 lipidation in Atg7-/- gastrocnemius muscles and (B) in 
Atg7-/- satellite cells.(C) Immunoblot analysis of Atg7 and LC3 in homogenates from different tissues. 
 
 
Autophagy inhibition in satellite cells induces muscle growth defects 
Atg7-/- mice showed a marked phenotype compared to control mice,characterized by 
very significant differences in body weight between control and Atg7-/- mice, with the 
last one very smaller than control littermates (figure 9A). 
 
Figure 9 Atg7 phenotype(A) Comparison of Atg7-/- and wild-type (WT) bodyweight  at 21 days of age. (B) 
Growth curve(C) Side-by-side comparison of various tissues including skeletal muscle from Atg7-/- and WT 
mice. (D) The weights of muscles and of various tissues were normalized to body weight. 
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In particular, the growth curve showed a severe reduction in body weight of Atg7-/- mice, 
that was significantly impaired between day 14 and 21 (figure 9B). The first 3 weeks of 
postnatal life in mouse is a period of intense growth, with body weight increasing 7-8 
fold, half of which is accounted for by the increasing in skeletal muscle [167] and in this 
phase satellite cells are essential to muscle growth. Normalizing all the organs weight to 
the body weight we demonstrated that only the quadriceps and gastrocnemius 
muscleswere smaller out-of-proportion to the body weight in Atg7-/- mice, suggesting 
that a defective autophagy in satellite cells population causes a muscular phenotype more 
serious, but with some similarities with NOS1 -/- mice, in spite of opposing autophagy 
conditions (figure 9C and 9D). 
 
Figure 10 (A)Hematoxylin and eosin staining in tibialis anterior of wild-type and Atg7-/- mice at P21 
(B) Immunofluorescence Laminin on tibialis anterior of Atg7-/- and WTmice. (C) Quantification of CSA in 
tibialis anterior and (D) representative distribution of CSA values and of wild-type and Atg7-/- mice.(E) 
qPCR analysis of mRNA levels for atrogin-1,muRF1 and Myostatin in gastrocnemius of wild-type and 
Atg7-/- mice. 
 
To better understand the nature of the hypotrophic skeletal muscle phenotype observed in 
Atg7 -/- mice, tibialis anterior muscle sections from male Atg7-/- and control mice at p21 
days after birth were stained by hematoxylin and eosin (H&E) (figure 9E) or 
immunostained with an anti-Laminin antibody (figure 9F). The overall morphology of the 
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tibialis anterior of Atg7-/- mice was normal, without pathological features such as 
necrosis, macrophage infiltration and centronucleated fibers, conversely laminin staining 
revealed a significant decrease in the mean CSA in Atg7-/- mice when compared with 
control littermates (figure 9G and 9H). 
The decrease of muscle mass can be due to activation of atrophic pathway or alteration of 
pathways involved in the regulation of skeletal muscle growth such as the Myostatin 
pathway. We examined the mRNA levels of Myostatin[168], MuRF1 and Atrogin[142] 
for atrophic pathway and none of them were significantly altered, demonstrating that loss 
of autophagy does not affect these pathways howeveris crucial for early postnatal skeletal 
muscle growth mostly dependent on satellite cells population (figure 9I).  
 
Loss of autophagy affects myoblast proliferation and cell fate decision 
Muscle growth during post-natal development (P0 to P21), but not at later stages, is 
accompanied by a continuous increase in the number of myonuclei resulting from 
satellite cell proliferation and fusion [165-166]. In Atg7 -/- mice at p21 the number of 
myonuclei of gastrocnemius muscle fibres were significantly decreased (figure 10C), 
when compared with the respective control suggesting a defect in the balance between the 
proliferation of satellite cells, and their differentiation into muscle fibers. 
 
Fig 11 (A) qPCR analysis of mRNA levels for atrogin-1,muRF1 and Myostatin in gastrocnemius muscle of 
wild-type and Atg7-/- mice.(B) Number of α7 integrin positive cells in skeletal muscle of wild-type and 
Atg7-/- mice. (C) Number of Myonuclei of  isolated Myofibers obtained from wt and Atg7 -/- at p21 (D) 
Number of satellite cells on isolated myofibersobtained from wt and Atg7 -/- at p21 at two time points: after 
isolation (p0) and at 72h of proliferation 
 
The myogenic regulatory factors MyoD and Myogenin are the major components 
controlling satellite cell activity. The expression patterns of these two proteins provide 
some of the signals crucial for satellite cell progeny proliferation, differentiation into 
myocytes, or returning to quiescence [34, 169]. Thus, as surrogate markers of satellite 
cells activity in muscle; we evaluated the expression of MyoD and Myogenin and as 
expected Atg7-/- muscle showed significant reduction of both markers compared to 
control (figure 10A), confirming a defect of satellite cells population in muscle of Atg7-/- 
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mice. Since an impairment of satellite cells function can be related to reduction in muscle 
stem cell number, we determined the percentage of satellite cells resident in muscle after 
labeling withα7 integrin antibody and analysis through flow cytometry (figure 10B) 
excluding cells positive for CD45, CD31, SCA. Our results showed no significant 
differences in the average number of α7 integrin positive cells in tibialis anterior of Atg7-
/- and control mice. Accordinglyon freshly isolated single myofibers,  the average 
number of satellite cells labeled with Pax7 and MyoD antibodies was similar in Atg7 -/- 
and controls mice (figure 10D).Conversely after 72 h of proliferation in growth medium 
condition, when satellite cells undergo their first divisions, Atg7-/- fibers displayed 
significantly fewer satellite cells than controls (Figure 10D). This last finding suggests 
that the loss of autophagy in satellite cells population can affect the proliferation rate of 
these cells. 
 
Figure12 Loss of autophagy affects myoblast proliferation. (E) CytoTrack Cell Proliferation Assay 
analysis on isolated satellite cells (F) Number of proliferating Ki67+ satellite cells on isolated myofibers 
obtained from wt and Atg7 -/- at p21 at two time points: after isolation(p0) and at 72h of proliferation 
immunofluorescence for Pax7 and MyoD on single myofibres obtained from wt and Atg7 / mice at p21 (G) 
and quantification of satellite cells population on isolated myofibers(H) at two time points: after isolation 
and at 72h of proliferation 
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To deepen this aspect, satellite cells isolated from Atg7-/- and control muscles, were 
labeled with CytoTrack Cell Proliferation Assay Kits and then monitored after 24 and 
48h of proliferation by flow cytometry. In agreement with the results obtained on single 
muscle fibers the analysis of CytoTrack Cell Proliferation Assay dye dilution showed a 
lower proliferation rate of Atg7-/- satellite cells compared to control satellite cells (Figure 
12A). To gain further insight into the role of autophagy on satellite cells we evaluated the 
myogenic cell determination on isolated myofibers after isolation and at 72h of 
proliferation in growth condition. Analyzing immunofluorescence for Pax7 and MyoD 
we observed that the number of MyoD+/Pax7-(cells committed to differentiate) 
decreased in Atg7-/- fibers (figure 12B). There was no significant differences in the 
number of MyoD+/Pax7+ cells (activated cells), whereas there was an increased number 
of Pax7+/MyoD-(quiescent cells) cells in Atg7-/- fibers, suggesting a delay of satellite 
cells to progress into myogenic lineage and the presence of more cells in quiescent state 
(figure 12C). 
Finally, to investigate whether loss of autophagy also regulates the ability of satellite cells 
to fuse and differentiate, myoblasts isolated from Atg7-/- and control mice were grown 
and differentiated in vitro. The cells were seeded and allowed to proliferate for 2 days 
before serum with drawalfor 48h. After this time myotubes were stained with MF20 and 
myonuclei were counted determining a fusion index (figure 13A)- This experiment 
demonstrated a reduced ability for Atg7 -/- satellite cells to fuse (figure 13B) into 
myotubesand moreover the myotubes in Atg7 -/- condition were smaller than control as 
shown by thesharp (figure 13C) decrease in myotubes diameter. 
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Figure 13 Fusion index analysis in wt and Atg7 -/- mie(A) immunofluorescence analysis of myotubes after 
48h of differentiation of cultured satellite cells isolated from oAtg7-/- and control muscle and stained with 
the monoclonal antibody against MyHC  (B) Fusion index quantification(C) measurement of myotubes 
diameter. 
 
Taken together, our data suggest that autophagy is involved in the control of satellite cells 
functions. Autophagy loss of function in satellite cells impairs their proliferation rate as 
well as their capability to fuse and differentiate and these results explain, at least in part, 
because the muscles of the Atg7-/- mice are smaller than the muscles of control mice. 
Surprisingly this condition is more severe but similar to another model of muscle 
wasting, NOS1 -/- mice, in which autophagy is enhanced due to mitochondrial defects, 
suggesting that unbalanced autophagic process during muscle development can affect in 
different ways regenerating population impairing their proliferation/differentiation 
capacity and compromising muscle formation in the early stage of development. 
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DISCUSSIONS 
This PhD thesis is divided in two sections: the formeris focused on the study of the 
relationship among the NO pathway, the mitochondrial structure/activity and skeletal 
muscle wasting, paying particular attention on the role of autophagy and using a mouse 
model in which NOS1 (nNOSµ) is absent. The latter has examined the role of autophagy 
in myogenic precursor cells(satellite cells) and muscle development utilizing a model of 
skeletal muscle specific autophagy-deficient mice (Atg7-/- mice). 
The first important observation of this project is that nNOSµ deficiency is per se 
sufficient to induce profound defects in mitochondria, with alterations in mitochondrial 
distribution, shape, morphology and size accompanied by a latent mitochondrial 
dysfunction. Nitric oxide has several key functions in mitochondria: it inhibits 
mitochondrial fission, induces mitochondrial biogenesis and controls mitochondrial 
respiratory rate by reversible inhibition of complex IV in the mitochondrial respiratory 
chain [3, 5, 170]. Furthermore, it controls the expression of several enzymes in the Krebs 
cycle [171]. Derangement of these mitochondrial functions is most likely at the basis of 
the multiple mitochondrial deficits we observed in NOS1-/- mice. The correlation 
between mitochondrial defects and muscle impairment is an important aspect we 
highlight in this project. Alterations in the content, shape or function of the mitochondria 
appear to occur in damaged muscle and inhibition of mitochondrial fission protects from 
muscle loss during fasting [153]. Recent findings have also underlined the crucial role of 
autophagy in the control of muscle mass and functions [134, 152, 165]. Autophagy 
derangement is involved in a number of inherited muscle diseases [172] end of interest, 
mitochondria are involved in regulating autophagy[173]. We found an increase of 
autophagy shown by the increase in expression of molecules relevant to autophagic 
signalling, namely p62, Bnip3 and Atg4 in nNOSµ muscle deficient. This suggests that 
nNOSµ deficiency leads to a sufficiently severe mitochondrial deficit but also a enhanced 
autophagic response that were normalised when the cGMP-dependent signaling was 
activated, indicating that these events are controlled by NO via its physiological second 
messenger cGMP. 
The second relevant information is that an altered NO system leads to impairment of 
muscle growth in postnatal phase. We found that skeletal muscles in the absence of 
nNOSµ are smaller relative to the rest of the body, thus indicating that muscle mass 
decrease was not simply attributable to a generalised decreased body mass tissues 
(including adipose tissue) and likely due to a specific reduction in the size of the muscle 
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fibres themselves. In agreement with this, NOS1-/- mice muscles displayed smaller 
myofibre CSA when compared to littermate controls, although they did not show any 
pathological features reminiscent of muscle damage, such as inflammation, necrosis or 
fibrosis. That the decrease in muscle mass is due to mechanisms other than the decrease 
in body mass was recently suggested using NOS1-/- mdx mice [174]. The deficiency of 
nNOSµ is also accompanied by muscle ageing [175] and fibre growth was prevented in 
the NOS1-/- mice model of skeletal muscle hypertrophy [176] and NOS1-/- mdx mice. 
Furthermore, the observation that at different time point NOS1-/- and control mice 
expressed similar levels of transcripts encoding the classical atrophygenes atrogin-1 and 
MuRF1, indicates that the atrophy pathways do not play a key role in the development of 
NOS1-/- muscles.  
Moreover, in this model the absence of NOS1 altered mitochondrial homeostasis and 
autophagic pathway in myogenic precursor cells with a decrease in the number of 
myonuclei per fibres and impaired muscle development at early stages of growth. This 
suggests that fusion of myogenic precursor cells during perinatal myogenesis is impaired. 
Accordingly, NO has been shown to stimulate the ability of myogenic precursor cells to 
become activated and fuse to each other [70, 73, 154]. There is a general agreement that 
mitochondria change when the myoblasts differentiate into myotubes. Also, NO 
maintains functional mitochondria and this permits differentiation of myogenic precursor 
cells in vitro. An altered NO signaling in myogenic precursor cells led to mitochondrial 
network fragmentation and increased autophagy induction resulting in significant defects 
in myogenesis process both in vivo and in vitro, decreasing muscle development. 
In conclusion, the first part of this work suggests that NO regulates key homeostatic 
mechanisms in skeletal muscle, namely mitochondrial bioenergetics and autophagy and 
influences the fate of satellite cells population and their ability to stimulate muscle 
development.  
Mitochondrial dysregulation and autophagy induction alter satellite cells behaviorand 
differentiation capacity leading to muscle wasting. Of notice, autophagy is essential to 
maintain muscle mass and impaired autophagy is known to induce skeletal myofiber 
degeneration and muscle weakness [136-137], but its role on regenerating satellite cells 
and its impact on muscle growth and development has not been evaluated yet. 
Toward this goal, in the second part of my PhD project we generate a transgenic mice in 
which autophagy is selectively inhibited in satellite cells, crossing Atg7-floxed mice with 
a transgenic line expressing Cre recombinase under the control of the Pax7 promoter.The 
67 
 
paired‐box gene Pax7 has been chosen since it has been reported that homozygous Pax7 
mutant mice completely lack muscle satellite cells, thus suggesting that Pax7 is at the top 
of the molecular hierarchy controlling satellite cell specification and it may be considered 
as a major regulator of satellite cell renewal and propagation [177]. 
Measuring body weight after birth we detected very significant differences between 
control and Atg7 -/- mice with the last one smaller than control littermates. Normalizing 
all the organs weight to the body weight we demonstrated that only the skeletal muscle 
tissue was smaller out-of-proportion to the body weight in Atg7-/- mice. KO mice 
presented with reduced myofiber cross sectional area, absent centralized myonuclei and 
any difference in the expression of atrophy markers, MuRF-1 and Atrogin-1 or 
Myostatin, indicating absence of skeletal muscle degeneration (18) and suggesting that a 
defective autophagy in satellite cells population causes a muscular phenotype more 
serious, but with some similarities with NOS1 -/- mice, in spite of opposing autophagy 
conditions. 
Reduced myofiber size, probably resulted from defective satellite cells function in 
muscle, indicated that the loss of Atg7 in Pax7 progenitors affected myocyte size, 
supporting the contribution of autophagy to skeletal muscle development. Thus, this 
study identifies autophagy as an important new regulator of postnatal myogenesis that is 
required for normal muscle growth, maintenance, and regeneration. Skeletal muscle 
postnatal growth is dependent on the expansion of satellite cells and on the balance 
between their proliferation and differentiation into muscle fibers. Indeed embryonic 
muscle development inPax7 germ line null mice is grossly normal[178]; however, 
postnatal muscle growth and regeneration in these mice is severely impaired [23, 179] 
proving that Pax7 cells contribute to adult myonuclei. 
Many diseases involving muscle wasting such as congenital myotonic dystrophy are 
suggested to involve impaired satellite cell function [180] and several studies have 
demonstrated the importance of autophagy in the maintenance and function of stem cells 
[181]. One of these studies, in which atg7 is genetically knocked out in Myf5+ progenitor 
cells that give rise to muscle and brown adipose tissue, demonstrated the requirement for 
autophagy in proper brown fat and skeletal muscle development [182]. Another recent 
study using a hematopoietic stem cell(HSC) specific knockout of atg7 suggests that 
inhibition of autophagy may lead to a loss of quiescence [183]. Other studies perturbing 
metabolic pathways that may regulate autophagy show defects in the maintenance of 
quiescence. Here, we show that autophagy loss of function in satellite cells impairs their 
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proliferation rate as well as their capability to fuse and differentiate. Furthermore, 
analyzing immunofluorescence for Pax7 and MyoD on isolated myofibers we observed 
that the number of cells committed to differentiate decreased in Atg7-/- fibers, whereas 
the number of quiescent cells increased, suggesting a delay of satellite cells to progress 
into myogenic lineage and the presence of more cells in quiescent state. Therefore, it is 
likely that the delayed muscle growth inAtg7-/- mice is due to satellite cell/myoblast 
dysfunction. 
Regarding the precise nature of this dysfunction, the exit of a stem cell out of quiescence 
into an activated state to differentiate is characterized by major metabolic changes 
associated with increased biosynthesis of proteins and macromolecules. The regulation of 
this transition is poorly understood. Autophagy, which catabolizes intracellular contents 
to maintain proteostasis and to produce energy during nutrient deprivation, was induced 
and its inhibition can suppress the increase in ATP levels and delayed satellite cell 
activation and differentiation [184].  
Stem cells have unique metabolic hallmarks that characterize their quiescent, 
proliferative, and differentiated states [185]. For instance, quiescent HSCs, which have 
low mitochondrial content and oxidative activity, primarily generate ATP from glycolysis 
rather than oxidative phosphorylation [186-187]. Proliferating cells, on the other hand, 
have an increased demand for biogenesis and primarily use oxidative phosphorylation to 
generate ATP [188]. As proliferating cells cycle, aerobic ATP production and oxidative 
phosphorylation fluctuate, increasing in G1 phase [189]. In fact, without sufficient energy 
and metabolites, proliferating cells will arrest in G1 phase [190].  
Furthermore, a recent study of Rando et coll., show that the inhibition of autophagy, 
obtained by using pharmacological and siRNA approaches to inhibit it acutely,does not 
lead to a loss of satellite cells quiescence but rather delays the activation of these cells out 
of the quiescent state. This study demonstrating that autophagy contributes to the 
metabolic adaptation that satellite cells undergo during activation add to the 
understanding of the importance of metabolic flexibility in stem cell fate determination. 
Stem cells adapt their energy usage and production via the manipulation of different 
metabolic pathways to support the changing bioenergetic needs during quiescence, 
proliferation, differentiation, or self-renewal [185](36). All these studies suggest that the 
activation out of quiescence is an example of a stem cell function that requires rapid and 
dramatic changes in the metabolic activity and that the induction of autophagic activity 
may be a critical component of those metabolic shifts.  
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In summary, the data presented here are of major importance to understand the 
mechanisms and pathways that govern muscle growth and repair processes.In two 
different models of muscle wasting characterized by two opposite autophagic conditions 
we detect similar defects in the myogenic precursor population, but with a different 
extent. In NOS1-/- the upregulation of autophagy induces a mild muscle phenotype 
associated with slower skeletal muscle development, but not with atrophic program. This 
defects is due to satellite cells impairments causing reduced proliferation and fusion 
during perinatal myogenesis. Similarly, in absence of autophagy specifically in satellite 
cells, their proliferation and fusion is marked impaired resulting in reduced skeletal 
muscle growth and development with the onset of a severe phenotype. 
The study of these two different transgenic mice reveals as in muscle unbalanced 
autophagy duringthe early phase of growth affects satellite cells population causing 
muscle wasting and suggests how during skeletal muscle development is important to 
have appropriate levels of autophagy. 
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